US20030175774A1 - Single-tube, ready-to-use assay kits and methods using same - Google Patents

Single-tube, ready-to-use assay kits and methods using same Download PDF

Info

Publication number
US20030175774A1
US20030175774A1 US10/335,690 US33569003A US2003175774A1 US 20030175774 A1 US20030175774 A1 US 20030175774A1 US 33569003 A US33569003 A US 33569003A US 2003175774 A1 US2003175774 A1 US 2003175774A1
Authority
US
United States
Prior art keywords
assay
information
container
kit
data storage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/335,690
Other versions
US20040063109A2 (en
Inventor
Michael Hunkapiller
Dennis Gilbert
Kenneth Livak
Junko Stevens
Susan Eddins
Michael Lucero
Original Assignee
Applera Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applera Corp filed Critical Applera Corp
Priority to US10/335,690 priority Critical patent/US20040063109A2/en
Priority to EP03707532A priority patent/EP1483405A4/en
Priority to PCT/US2003/002238 priority patent/WO2003064670A1/en
Priority to EP03707531A priority patent/EP1468103A4/en
Priority to AU2003209375A priority patent/AU2003209375A1/en
Priority to JP2003564261A priority patent/JP2005515785A/en
Priority to PCT/US2003/002240 priority patent/WO2003065000A2/en
Priority to US10/404,640 priority patent/US20040072195A1/en
Publication of US20030175774A1 publication Critical patent/US20030175774A1/en
Publication of US20040063109A2 publication Critical patent/US20040063109A2/en
Priority to JP2006183943A priority patent/JP2006294059A/en
Priority to US12/404,674 priority patent/US20090239290A1/en
Priority to US12/408,870 priority patent/US20090239233A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6858Allele-specific amplification
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/54Labware with identification means
    • B01L3/545Labware with identification means for laboratory containers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/00584Control arrangements for automatic analysers
    • G01N35/00594Quality control, including calibration or testing of components of the analyser
    • G01N35/00613Quality control
    • G01N35/00663Quality control of consumables
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06QINFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q30/00Commerce
    • G06Q30/06Buying, selling or leasing transactions
    • G06Q30/0601Electronic shopping [e-shopping]
    • G06Q30/0621Item configuration or customization
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06QINFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q30/00Commerce
    • G06Q30/06Buying, selling or leasing transactions
    • G06Q30/0601Electronic shopping [e-shopping]
    • G06Q30/0633Lists, e.g. purchase orders, compilation or processing
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06QINFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q30/00Commerce
    • G06Q30/06Buying, selling or leasing transactions
    • G06Q30/0601Electronic shopping [e-shopping]
    • G06Q30/0641Shopping interfaces
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06QINFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q50/00Systems or methods specially adapted for specific business sectors, e.g. utilities or tourism
    • G06Q50/10Services
    • G06Q50/22Social work
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G16B30/10Sequence alignment; Homology search
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G16B30/20Sequence assembly
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B35/00ICT specially adapted for in silico combinatorial libraries of nucleic acids, proteins or peptides
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B35/00ICT specially adapted for in silico combinatorial libraries of nucleic acids, proteins or peptides
    • G16B35/20Screening of libraries
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00ICT programming tools or database systems specially adapted for bioinformatics
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00ICT programming tools or database systems specially adapted for bioinformatics
    • G16B50/10Ontologies; Annotations
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16CCOMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/60In silico combinatorial chemistry
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/02Identification, exchange or storage of information
    • B01L2300/021Identification, e.g. bar codes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/54Labware with identification means
    • B01L3/545Labware with identification means for laboratory containers
    • B01L3/5453Labware with identification means for laboratory containers for test tubes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B45/00ICT specially adapted for bioinformatics-related data visualisation, e.g. displaying of maps or networks

Definitions

  • PCR Polymerase chain reaction
  • DNA deoxyribonucleic acid
  • PCR requires the use of several assay reagents as well as a target analyte, such as a target polynucleotide.
  • the target analyte can be contained in a sample and amplified during a PCR process. During the course of the reaction, the target analyte can be amplified many times.
  • the assay reagents must be gathered and mixed, typically immediately prior to subjecting the sample to PCR.
  • the many assay reagents are typically obtained from multiple sources and typically mixed together on a laboratory bench top in a physical location that commonly houses laboratory equipment necessary to perform PCR.
  • an assay kit includes: a container containing assay reagents; and a separate data storage medium that contains data about the assay reagents.
  • the assay reagents can be adapted to perform an allelic discrimination or expression analysis reaction when admixed with at least one target polynucleotide.
  • the other reagents can be, for example, components conventionally used for polymerase chain reactions (PCR), and can include non-reactive components.
  • the container can be sealed and can be packaged with the separate data storage medium in a package, for example, in a box.
  • the container can have a machine-readable label that provides information about the contents of the container.
  • the data stored on the data storage medium can include computer-readable code that can be used to adjust, calibrate, direct, set, run, or otherwise control an apparatus, for example, a scientific or laboratory instrument.
  • methods are provided wherein the data is used to cause an apparatus to automatically perform a polymerase chain reaction of a target analyte that is mixed with the assay reagents. Methods are also provided whereby the kit is shipped to a customer.
  • FIG. 1 is a top plan segmented view of a plurality of containers in a shipping and storage tray that can be included in a kit, according to various embodiments;
  • FIG. 2 is a side view of a container of one of the containers shown in FIG. 1;
  • FIG. 3 is a compact disk that can be included in a kit according to various embodiments
  • FIG. 4 is a flowchart outlining a method of use of a container and a data storage medium according to an embodiment
  • FIG. 5 is a schematic diagram of a quenchable dye that can be part of a mixture of reagents according to various embodiments.
  • an assay kit can include, for example: a container containing assay reagents; and a separate data storage medium that contains data about the assay reagents.
  • the assay reagents can include reagents adapted to perform an allelic discrimination or expression analysis reaction when admixed with at least one target polynucleotide sequence.
  • Reagents can be, for example, reagents used for polymerase chain reaction (PCR) amplification, ligase chain reaction (LCR), oligonucleotide reaction assays (OLA), self-sustaining sequence replication, enzyme kinetic studies, homogeneous ligand binding assays, deoxyribonucleic acid or amino acid sequencing, and/or other chemical or biochemical reaction, and can include non-reactive components.
  • the container can be sealed and can be packaged with the separate data storage medium in a package, for example, in a box.
  • the container can have a machine-readable label that provides information about the contents of the container.
  • nucleic acid analogs can be used in addition to or instead of nucleic acids.
  • nucleic acid analogs includes the family of peptide nucleic acids (PNA), wherein the sugar/phosphate backbone of DNA or RNA has been replaced with acyclic, achiral, and neutral polyamide linkages.
  • PNA peptide nucleic acids
  • a probe or primer can have a PNA polymer instead of a DNA polymer.
  • the 2-aminoethylglycine polyamide linkage with nucleobases attached to the linkage through an amide bond has been well-studied as an embodiment of PNA and shown to possess exceptional hybridization specificity and affinity.
  • An example of a PNA is as shown below in a partial structure with a carboxyl-terminal amide:
  • Nucleobase as used herein means any nitrogen-containing heterocyclic moiety capable of forming Watson-Crick hydrogen bonds in pairing with a complementary nucleobase or nucleobase analog, e.g. a purine, a 7-deazapurine, or a pyrimidine.
  • Typical nucleobases are the naturally occurring nucleobases such as, for example, adenine, guanine, cytosine, uracil, thymine, and analogs of the naturally occurring nucleobases, e.g.
  • Nucleoside refers to a compound consisting of a nucleobase linked to the C-1′ carbon of a sugar, such as, for example, ribose, arabinose, xylose, and pyranose, in the natural ⁇ or the ⁇ anomeric configuration.
  • the sugar can be substituted or unsubstituted.
  • Substituted ribose sugars can include, but are not limited to, those riboses having one or more of the carbon atoms, for example, the 2′-carbon atom, substituted with one or more of the same or different Cl, F, -R, -OR, -NR 2 or halogen groups, where each R is independently H, C 1 -C 6 alkyl or C 5 -C 14 aryl.
  • Ribose examples can include ribose, 2′-deoxyribose, 2′,3′-dideoxyribose, 2′-haloribose, 2′-fluororibose, 2′-chlororibose, and 2′-alkylribose, e.g. 2′-O-methyl, 4′- ⁇ -anomeric nucleotides, 1′- ⁇ -anomeric nucleotides, 2′-4′- and 3′-4′-linked and other “locked” or “LNA”, bicyclic sugar modifications.
  • Exemplary LNA sugar analogs within a polynucleotide can include the following structures:
  • B is any nucleobase.
  • Sugars can have modifications at the 2′- or 3′-position such as methoxy, ethoxy, allyloxy, isopropoxy, butoxy, isobutoxy, methoxyethyl, alkoxy, phenoxy, azido, amino, alkylamino, fluoro, chloro and bromo.
  • Nucleosides and nucleotides can have the natural D configurational isomer (D-form) or the L configurational isomer (L-form).
  • the nucleobase is a purine, e.g. adenine or guanine
  • the ribose sugar is attached to the N 9 -position of the nucleobase.
  • the nucleobase is a pyrimidine, e.g. cytosine, uracil, or thymine
  • the pentose sugar is attached to the N 1 -position of the nucleobase.
  • Nucleotide refers to a phosphate ester of a nucleoside and can be in the form of a monomer unit or within a nucleic acid.
  • Nucleotide 5′-triphosphate refers to a nucleotide with a triphosphate ester group at the 5′ position, and can be denoted as “NTP”, or “dNTP” and “ddNTP” to particularly point out the structural features of the ribose sugar.
  • the triphosphate ester group can include sulfur substitutions for the various oxygens, e.g. ⁇ -thio-nucleotide 5′-triphosphates.
  • polynucleotide and oligonucleotide mean single-stranded and double-stranded polymers of, for example, nucleotide monomers, including 2′-deoxyribonucleotides (DNA) and ribonucleotides (RNA) linked by internucleotide phosphodiester bond linkages, e.g. 3′-5′ and 2′-5′, inverted linkages, e.g. 3′-3′ and 5′-5′, branched structures, or internucleotide analogs.
  • DNA 2′-deoxyribonucleotides
  • RNA ribonucleotides linked by internucleotide phosphodiester bond linkages, e.g. 3′-5′ and 2′-5′, inverted linkages, e.g. 3′-3′ and 5′-5′, branched structures, or internucleotide analogs.
  • Polynucleotides can have associated counter ions, such as H + , NH 4 + , trialkylammonium, Mg 2+ , Na + and the like.
  • a polynucleotide can be composed entirely of deoxyribonucleotides, entirely of ribonucleotides, or chimeric mixtures thereof.
  • Polynucleotides can be comprised of internucleotide, nucleobase and sugar analogs.
  • a polynucleotide or oligonucleotide can be a PNA polymer.
  • Polynucleotides can range in size from a few monomeric units, e.g.
  • oligonucleotides when they are more commonly frequently referred to in the art as oligonucleotides, to several thousands of monomeric nucleotide units. Unless otherwise denoted, whenever a polynucleotide sequence is represented, it will be understood that the nucleotides are in 5′ to 3′ order from left to right and that “A” denotes deoxyadenosine, “C” denotes deoxycytidine, “G” denotes deoxyguanosine, and “T” denotes thymidine, unless otherwise noted.
  • Internucleotide analog as used herein means a phosphate ester analog or a non-phosphate analog of a polynucleotide.
  • Phosphate ester analogs can include: (i) C 1 -C 4 alkylphosphonate, e.g. methylphosphonate; (ii) phosphoramidate; (iii) C 1 -C 6 alkyl-phosphotriester; (iv) phosphorothioate; and (v) phosphorodithioate.
  • Non-phosphate analogs can include compounds wherein the sugar/phosphate moieties are replaced by an amide linkage, such as a 2-aminoethylglycine unit, commonly referred to as PNA.
  • Heterozygous as used herein means both members of a pair of alleles of a gene are present in a sample obtained from a single source, wherein a gene can have two alleles due to, for example, the fusion of two dissimilar gametes with respect to the gene.
  • Heterozygous assay as used herein means an assay adapted to identify the allelic state of a gene having one or both members of a pair of alleles.
  • Homozygous as used herein means one member of a pair of alleles is present in a sample obtained from a single source, wherein a gene can have one allele due to, for example, the fusion of two identical gametes with respect to the gene.
  • Homozygous assay as used herein means an assay adapted to identify only one of two possible allelic states of a gene having one or both members of a pair of alleles.
  • the container can contain all assay reagents and components necessary to conduct PCR, with the exception of a target polynucleotide, also referred to as a target nucleic acid sequence or a target DNA.
  • the target polynucleotide can be provided by a user and mixed with the assay reagents or the target polynucleotide can be provided to the user in a second container to be mixed with the assay reagents.
  • the kit can include a container that contains a target polynucleotide and a container that does not contain a target polynucleotide.
  • the container can be a tube, vial, jar, capsule, ampule, or like vessel.
  • the tube can have a removable cap and/or a replaceable cap.
  • the cap can maintain the container sealed such that the container is water-tight and air-tight.
  • the container can be hermetically sealed.
  • the container can be open at a first end and closed at a second end.
  • the first end can be tapered, for example, along the length of the container.
  • the container can hold a mixture including assay reagents and have a volume of at least about 5 ⁇ L.
  • the container can have a volume of about 10 ⁇ L or less.
  • the maximum volume of the container can be about 25 ⁇ L or less, and according to other embodiments, the volume can be greater than about 25 ⁇ L.
  • standardized assay designs are provided for custom assays and/or stock assays, including either universal concentration or uniform thermal cycling parameters, or both, allowing results to be more easily compared with and/or transferred to other researchers and labs.
  • assays are formulated in a single-tube 20 ⁇ mix format that is convenient and easy to use, requiring no preparation or clean-up and providing faster time to results.
  • the assay reagents in the container can contain a volume of assay reagents for more than one respective assay.
  • the assay reagents in the container can be divided and transferred into five respective reaction wells, for example, to conduct five identical and/or different assays.
  • the assay reagents in the container can be removed from the container and aliquoted into ten respective reaction wells.
  • the container can contain a sufficient volume of assay reagents to complete at least 1, at least 5, at least 10, or at least 25 assays.
  • the container can have a label that provides information about the contents of the container.
  • the label can be secured to the container, or to the cap of the container, if desired.
  • the label can comprise a barcode and can comprise a 2-dimensional barcode that can be provided on the container.
  • the label can include a serial number, a lot number, a date, and/or other identifying or descriptive indicia.
  • the label can identify the reporter dye or dyes in the container.
  • the label can provide sequence information regarding polynucleotide or peptide reagents provided in the container.
  • the label can contain information about the target polynucleotide sequence, including a common or scientific name or gene name for the target polynucleotide or sequence information about a target analyte.
  • the assay kit can be packaged in, for example, a box. Packaging such as a carton or box can instead or additionally be labeled with identifying and/or descriptive indicia and/or coating as described above.
  • an English-language label with the assay name can be located on each tube.
  • a 2-D barcode can be laser-etched on the bottom of each assay tube and a 1-D barcode can be laser-etched on each 96-tube rack of assays, thereby making the assay tubes and racks machine-identifiable so that the assays are compatible with automation for high throughput applications.
  • the container can contain at least one probe reactive with a target polynucleotide, wherein the probe can include a polynucleotide, a marker compound, for example, a marker dye, a quenchable dye, or a fluorescent reporter dye, a non-fluorescent quencher, a minor groove binder, or a combination thereof.
  • a marker compound for example, a marker dye, a quenchable dye, or a fluorescent reporter dye, a non-fluorescent quencher, a minor groove binder, or a combination thereof.
  • the probe can include a reporter dye such as VIC or 6-FAM linked to the 5′ end of the polynucleotide.
  • VIC and 6-FAM dye-labeled probes are available from Applied Biosystems, Foster City, Calif.
  • the minor groove binder can increase the melting temperature T m without increasing the length of the polynucleotide. This can result in greater differences in T m values between matched and mismatched probes that therefore enables more accurate allelic discrimination.
  • the probe can include a quencher (e.g., a non-fluorescent quencher) linked to the 3′ end of the polynucleotide. The quencher can inhibit fluorescence that can facilitate greater discrimination of reporter dye fluorescence.
  • the container can contain two different types of probes, wherein the polynucleotide and the reporter dyes differ.
  • the first type of probe can have a first polynucleotide with a VIC reporter dye attached to the 5′ end of the first polynucleotide and the second type of probe can have a second polynucleotide with a 6-FAM reporter dye attached to the 5′ end of the second polynucleotide and the first and second polynucleotides differ by at least one monomeric unit at the same location in the polynucleotide when the polynucleotides are aligned 5′ to 3′.
  • the dye-labeled probes can be adapted to perform a heterozygous assay or a homozygous assay.
  • the probe can anneal to a complementary sequence between the forward and reverse primer sites. At the time of annealing, the probe is intact and the proximity of the reporter dye to the quencher can result in suppression of fluorescence of the reporter dye.
  • a polymerase can cleave a reporter dye only when the probe has completely, mostly, or substantially hybridized to the target polynucleotide sequence. When the reporter dye is cleaved from the probe, the relative fluorescence of the reporter dye increases. The increase in relative fluorescence can only occur if the amplified target polynucleotide sequence is complementary, mostly complementary, or substantially complementary to the probe. Therefore, the fluorescent signal generated by PCR amplification can indicate which alleles are present in a sample.
  • Mismatches between a probe and a target polynucleotide sequence can reduce efficiency of probe hybridization and/or a polymerase can be more likely to displace a mismatched probe without cleaving it and therefore not produce a fluorescent signal. For example, if one of two possible reporter dyes fluoresce during an assay, then the presence of a homozygous gene is indicated. For further example, if both possible reporter dyes fluoresce during an assay, then the presence of a heterozygous gene is indicated.
  • the container can contain at least one primer, wherein the primer can comprise a sequence that is shorter than the target polynucleotide.
  • the primer can comprise a polynucleotide and/or a minor groove binder.
  • the primer can comprise a sequence that is complimentary to, or mostly complimentary to, the target polynucleotide.
  • the primer can be at least 90% homologous to a corresponding length of the target polynucleotide, at least 80% homologous to a corresponding length of the target polynucleotide, at least 70% homologous to a corresponding length of the target polynucleotide, or at least 50% homologous to a corresponding length of the target polynucleotide.
  • the container can contain a thermostable DNA polymerase, such as, for example, thermos aquaticus (Taq), and at least 4 embodiments of a deoxyribonucleic acid (e.g., adenosine, tyrosine, cytosine, and guanine).
  • the polymerase can be, for example, AMPLITAQ GOLD, available from Applied Biosystems, Foster City, Calif.
  • the container can container components of a fluorogenic 5′ nuclease assay or other assay reagents that utilize 5′ nuclease chemistry, for example, TAQMAN minor groove binder probes, available from Applied Biosystems, Foster City, Calif. Some or all of the above-listed components can be replaced by or used with commercially-available products, for example, buffers or AMPLITAQ GOLD PCR MASTER MIX (Applied Biosystems, Foster City, Calif.).
  • the assay kit can further include a target polynucleotide in the first or another container, for example, as can be used to prepare a positive control.
  • the assay kit can include more than one container and an Assay Information File (AIF) and/or Electronic Data Sheet (EDS) can be provided on the data storage medium and can contain information about the containers.
  • AIF Assay Information File
  • EDS Electronic Data Sheet
  • an AIF or EDS can contain information about 96 containers or 384 containers.
  • a multi-well plate can also be provided in the kit and can include, for example, 96 or 384 positions for container placement.
  • a plate can be substantially rectangular with an optional integrated structural feature for plate orientation.
  • a plate can have a plurality of wells.
  • the assay kit can include a plate adapted to hold a plurality of containers or tubes.
  • the plate can be of unitary construction.
  • One or more containers can be integrated into a single plate, and the plate can have a plurality of containers in physical contact with each other.
  • the plate can be of unitary construction and have 96 containers in the form of receptacles.
  • the plate can be of unitary construction and have 384 containers.
  • Assays may be delivered with certain sequence information.
  • sequence context information e.g., forward primer location in the RefSeq sequence
  • sequence context information can denote which exon-exon junction the assay covers so that users can get a sense of where the assay is positioned in the transcript. More information can be provided, as desired.
  • data can have the following columns (non-limiting examples are listed in paratheticalls following the item): customer name (assigned by the supplier); order number (assigned by the supplier, in some configurations, and can correspond to a number on a 1-D bar code on the plate); ship date (date shipped by the supplier); set ID (an assay name created from record information in the requestor's submission file, including record name and target site name from a target site coordinate; if the sequence record submitted contained multiple target sites, the value of the Set ID can be used to determine which site was used to create the assay); set No.
  • plate ID (assigned by the supplier, can include the order number value, and can appear on the plate rack as the 1-D bar code); vial ID (a 2-D bar code number can be attached to the bottom of each tube; entry in the datasheet may have leading zeros dropped in some configurations); well location (location of assay tube in the plate rack); line item (may be used for internal quality control by the supplier); VIC probe name (may be used for internal quality control by the supplier); VIC probe sequence (5′ to 3′ sequence of the probe labeled with VIC dye; in some configurations, the 3′ non-fluorescent quencher-minor groove binder (NFQ-MGB) may not be listed but is present on the probe); VIC ( ⁇ M) concentration (probe concentration); line item (may be used for internal quality control by the supplier); 6-FAM probe name (may be used for internal quality control by the supplier); 6-FAM probe sequence (5′ to 3′ sequence of the probe labeled with 6-FAM dye; in some configurations, the
  • the shipped worksheet can be provided to enable a user of the assays to determine that the tubes are in the same positions in the plate rack as when the assays were shipped.
  • the following columns can appear in the shipped worksheet: position (position in the plate); and/or vial ID (a 2-D bar code number that can be attached to the bottom of the tube; in some configurations, leading zeros are dropped).
  • the assay kit can be shipped to a customer.
  • the data storage medium can be shipped to the customer along with, concurrent to, separately, previously, or subsequently to shipment of the container and the contents of the container.
  • data can be transferred electronically to the customer.
  • the data can be sent to the customer by electronic mail.
  • the customer can retrieve or download the information over a computer network, such as, for example, the Internet, a Wide Area Network, a Local Area Network, or a Virtual Private Network.
  • the customer can retrieve the data using a file transfer protocol or by a hypertext transfer protocol.
  • the protocol can be secured using, for example, 128 bit encryption.
  • the manufactured assays are shipped as homogenous assays in a single tube format.
  • a single-tube, ready to use format is provided that is suitable for immediate use on an ABI PRISM® Sequence Detection System (SDS) instrument for one or more applications.
  • SDS Sequence Detection System
  • Data stored on the data storage medium can include information about a variety of items, for example, a stock number, an assay ID number, a plate number, a well location, a gene symbol or name, a category ID or name, a group ID or name, a chromosome number, a cytogenetic band identification, an NCBI gene reference, an NCBI SNP reference, a minor allele frequency, a minor allele frequency of a particular population, an SNP type, a context sequence, a reporter dye identification, barcode information, or a combination thereof.
  • the context sequence can include, for example, up to 20 bases, more than 20 bases, more than 30 bases, or more than 40 bases.
  • the data stored on the data storage medium can include information about some of the previously-mentioned items, all of the previously-mentioned items, or none of the previously-mentioned items. Furthermore, the information can include more information than that information listed above and/or other identifying or descriptive indicia.
  • the data storage medium can be separate from the container or can be affixed to the container.
  • the data storage medium can be a label attached to the container, for example, with a pressure sensitive adhesive or other glue.
  • the container or cap can serve as the data storage medium and the data can be printed, etched, inscribed, or otherwise encoded on a surface of the container or cap.
  • the data storage medium can include an optically detectable code and/or the data storage medium can be a 2-dimensional barcode.
  • the data can be stored on the data storage medium in electronic format.
  • the data storage medium can be a compact disk (CD).
  • the information can be contained in an Assay Information File (AIF) and/or the Assay Information File can be in the form of an ascii-compatible text file.
  • the data can be contained in an Electronic Data Sheet (EDS) and/or the EDS can be in the form of an ascii-compatible text file.
  • the EDS can contain information that links container identification information, such as, for example, the information contained on a 2-dimensional barcode on the container, to assay identification information.
  • the link can be to assay information contained in, for example, an Assay Information File.
  • the AIF, the EDS, or other computer-readable data or code contained or stored on the data storage medium can be adapted to control an apparatus such as a scientific or laboratory instrument, for example, a thermal cycler, or sequence detection system.
  • the data storage medium can, in addition or in the alternative, contain executable code.
  • the executable code can be in the form of stand-alone software, updates to stand-alone software, or modules to third-party software.
  • the software can be adapted to run on an operating system that controls an SDS instrument, such as, for example, UNIX.
  • the software can include computer code written in assembly language or machine language.
  • the software can be transferred to the SDS instrument by computer and can be saved onto a storage device in the SDS instrument, loaded into a memory device of the SDS instrument, incorporated into previously-loaded software on the SDS instrument, or can be overwritten onto previously-loaded software on the SDS instrument.
  • the storage device can be a hard drive or optical drive.
  • the memory device can be random access memory (RAM) or an erasable, programmable read only memory (EPROM) chip.
  • the software can be provided to a customer on a data storage medium or can be transferred to the customer over a computer network.
  • an Assay Information File (AIF) or Electronic Data Sheet (EDS) can be provided with an assay or assays.
  • the AIF and/or EDS can be, in some embodiments, electronic files or data electronically stored on a data storage medium.
  • the files or data can contain, for example, information on one or more assays, information on one or more polynucleotide sequences, an alphanumeric sequence representing a polynucleotide sequence, or the like.
  • a print copy or a printout of the AIF, EDS, and/or information in the AIF and/or EDS can be provided.
  • a printed copy of the AIF and/or EDS can also be provided and can contain information about each assay. This information may include, among other things, the position of each assay in the plate rack.
  • Some embodiments provide, either in place of, or in addition to the printed copy of the AIF and/or EDS, a CD-ROM with one or more data files recorded thereon.
  • the data may include any or all of the following files, and may include other files as well: an electronic assay workbook, including data sheet(s) and shipped worksheet(s); an electronically readable and/or printable copy of instructions for SNP assay protocol for ordering by design; an electronically readable and/or printable copy of protocols for submitting requests; and/or an electronically readable copy of a product insert.
  • a data sheet and/or an electronic assay workbook is provided with custom assays.
  • an electronic assay workbook is included with each order of up to 92 assays.
  • the workbook file name can include the number on a bar code for easy correlation.
  • the workbook can contain two worksheets, namely, a “data sheet” worksheet and a “shipped” worksheet.
  • the workbook can be a spreadsheet file, such as a MICROSOFT EXCEL spreadsheet software file, that may contain macros and/or be password protected. Cells of the workbook can be copied and pasted into a new worksheet and modified in the new worksheet.
  • a printed copy of the data from the electronic file may be included with a shipment of assays ordered, for example, by design.
  • the data can include a correlation of the 2-D barcodes on the tubes to the corresponding assay names and primer and probe specific information.
  • data included with an order can include at least some of the following information: an identification of the assay in each tube; assay names; which target site was used, if the requester submitted a sequence record that included more than one target site; locations of each tube in the assay rack; sequences of the primers and probes; and concentrations ( ⁇ M) of primers and probes.
  • Other configurations can necessarily include all of this information and may include more information.
  • a computer program comprised of lines of machine-readable and/or executable computer code, can obtain data contained in the AIF, EDS, or in another data file, and use the data to control a scientific or laboratory instrument.
  • a microcomputer-based software program can be provided that can load computer-readable data from an AIF or EDS.
  • the AIF or EDS can be stored, for example, on a compact disk that can be shipped to a user along with, concurrent to, previous to, or subsequent to shipping and providing the at least one container of the assay kit.
  • the software program can configure, direct, or operate an instrument that can perform PCR, sequencing, and/or sequence detection, for example, an Applied Biosystems 7900HT Sequence Detection System (SDS).
  • the software program can control, for example, an instrument, to perform PCR, sequencing, and/or sequence detection, without human intervention.
  • the SDS can directly operate and run without human interaction
  • the same or a different software program can perform basecalling of detected sequence data.
  • the kit can include a software program stored on the data storage medium or stored separately on a second data storage medium, for example, a CD.
  • the software program can build an internal assay information database from AIF or EDS files and/or generate plate information adapted to control, at least in part, an SDS instrument.
  • the software can deliver the plate information to the SDS.
  • the software program can flag or note problems with the plate information or plate setup data.
  • the software program can generate an activity log file.
  • the software can detect new plate information setup files, new AIF files, new EDS files, or a combination thereof.
  • the software can import data generated by the customer.
  • the software program can add to, modify, or delete data from an AIF or EDS.
  • the software program can control or direct an SDS instrument to perform, for example, PCR, sequencing, sequence detection, or a combination thereof.
  • the software program can control an SDS instrument to perform PCR, sequencing, or sequence detection using a protocol obtained from an AIF or EDS.
  • the software can receive data from an instrument, for example, from a real-time PCR or SDS instrument, wherein the data is generated during the course of, for example, PCR, sequencing, or sequence detection.
  • An SDS data file can be generated by an SDS instrument and can be transmitted to the software program.
  • the SDS data file can contain information generated by an SDS instrument, or information from an AIF or EDS stored on the data storage medium.
  • the SDS data file can contain error codes or error information generated by the SDS instrument as a result of problems with the SDS instrument, the AIF, and/or the EDS.
  • the data file can include error codes related to, for example, failure to detect at least one fluorescent probe or failure of a component of the SDS instrument, such as a heating element.
  • the SDS instrument can send a log file containing, for example, information about AIF or EDS files transmitted from the software program.
  • a detector list can be generated from an AIF or an EDS and saved in a format suitable for input to a detector manager, such as, for example, an ascii-compatible format.
  • the software can save an AIF, EDS, and/or SDS data file, or other file in separate, respective folders on a data storage device, for example, on a microcomputer.
  • the microcomputer can include, for example, a hard drive, an optical drive, or both.
  • the software program can remain in the memory of a microcomputer before, during, or after transmission of a data file to or from the software program.
  • the software program can continuously monitor data on a microcomputer for new or modified AIF, EDS, and/or SDS data files.
  • a manual method can be used by a customer or user of the assays to validate each tube position in the rack plate.
  • the rack plate position and assay name on the tube label can be compared with the values in the well location and set ID columns of the data.
  • This “validation” is different from the validation of assays, in that validation of each tube position in a plate rack is performed by the user, and merely confirms that the tubes are in positions matching the “shipped” worksheet. If the tubes are not in the correction position, they may be rearranged to match the worksheet.
  • the operational quality of the assays contained within the tubes is validated at the supplier's factory.
  • an automated method can be used by a customer to validate each tube position in the rack plate.
  • This method can include scanning the plate and tubes using a 2-D bar code reader, and executing a plate validation spreadsheet macro (for example, a MICROSOFT EXCEL spreadsheet software macro).
  • a plate validation spreadsheet macro for example, a MICROSOFT EXCEL spreadsheet software macro.
  • the plate rack can be placed on the 2-D bar code reader in a standard orientation. For example, tube position “A1” is placed in the top left corner of the reader.
  • the 1-D bar code on the plate rack can then be scanned.
  • the bar code reader can be configured, if necessary, to read positions in one column and to read bar codes in a column next to the positions column.
  • the plate rack is scanned and the results are saved to a director that can be accessed from the computer containing the electronic file. In some configurations, the scanning results are saved as a tab-delimited file.
  • the “shipped” worksheet can be opened in the spreadsheet and, with macros enabled, the validation macro can be run.
  • the validation is performed by opening the electronic workbook, clicking a mouse on a “shipped” tab to view the worksheet containing the validation macro, clicking on the “validate” button to start the plate validation macro, and, when an “import plate scan” dialog box is presented, selecting “browse” to locate the file from the 2-D bar code scan. After “browse” is selected, the file that resulted from the 2-D bar code scan is selected and imported into a new worksheet, which, in some embodiments, is called “received”.
  • the macro can then compare each bar code and its position in the plate rack with the corresponding bar code in the “shipped” worksheet (for example, a value in the “Vial: ID” column). The macro then enters the result in a “validation” column in the “shipped” worksheet. According to various embodiments, the results for each entry may either be “OK” (or any entry understood as indicating a match) or “ERROR” (or any other entry understood as indicating a non-match). A “shipment validation” dialog box can then alert that the validation is complete, and the user clicks “OK” to dismiss the dialog box.
  • Plate validation errors indicate that the tubes are not in the same position as they were shipped by the supplier to the requester.
  • the user can resolve plate validation errors by rearranging the tubes to match the “shipped” worksheet.
  • the user can then rescan the plate and execute the validation macro again to validate the plate.
  • an assay kit can be provided that includes at least one assay for allelic discrimination or expression analysis of genomic material.
  • An information source can be provided that has at least one member of the group consisting of an electronic data sheet, an assay information file, and at least one printed datasheet and combinations thereof.
  • the assay can be a SNP assay or a gene expression assay.
  • the assay can be provided in a single tube.
  • the assay can comprise at least one probe and two primers.
  • the assay can be a SNP assay comprising one probe for each of two alleles and two primers.
  • the probe can have at least one fluorophore and at least one fluorescence quencher.
  • the fluorescence quencher can be non-fluorescent fluorescence quencher.
  • the probe can have at least one minor groove binder.
  • the assay can have PCR reagents or RT-PCR reagents.
  • the assay can have universal master mix, where the universal master mix has at least one salt, a buffer, and a DNA polymerase.
  • the single tube can have a bar code label.
  • the bar code label can be a two-dimensional bar code label.
  • the single tube can have a human-readable assay number.
  • the kit can be comprised of a plurality of assays, each of which is in a single tube, thereby constituting a plurality of tubes.
  • the plurality of tubes can be contained in a rack and the rack can have a bar-code identification.
  • the kit can also have at least one datasheet containing information on the assay.
  • the kit can have at least one machine-readable medium containing information on the assay.
  • the at least one machine-readable medium can be at least one datasheet containing information on the assay.
  • the machine-readable medium can be a compact disk.
  • FIG. 1 is a plan sectional view of an embodiment of an assay kit having several containers 10 that are held in place for shipping in a tray 12 .
  • a 2-dimensional barcode 14 is located on the top side of a container cap 16 .
  • the 2-dimensional barcode 14 is adapted to be machine readable.
  • a serial number 18 is located next to the 2-dimensional barcode 14 .
  • the serial number 18 is printed in Arabic numerals.
  • FIG. 2 is a side view of one of the containers 10 shown in FIG. 1.
  • the container 10 has a 2-dimensional barcode 14 and a serial number 18 printed on a cap 16 for the container 10 .
  • the cylindrical body 20 of the container 10 is adapted to hold a mixture of assay reagents and is adapted to fit into a tray 12 for shipping and storage.
  • FIG. 3 is a compact disk 22 that can be included in an assay kit according to various embodiments, and can be provided to a user along with a container (not shown in FIG. 3) containing a mixture including assay reagents.
  • FIG. 4 is a flowchart outlining a method of use of a container and a data storage medium according to an embodiment.
  • a customer can request one or more assays from a supplier.
  • the customer receives from the supplier a CD containing an electronic data file and an assay container or containers, and loads the CD into a CD reader of a computer (e.g., a microcomputer) having software that can communicate with an SDS instrument, for example, an ABI 7900HT system.
  • the software on the microcomputer detects the new electronic data file on the CD and loads the electronic data file into memory.
  • the software can read the contents of the electronic data file and can: build an internal assay information database from the electronic data file; flag problems with any file necessary to run or operate the SDS instrument; generate or update an activity log; and monitor for any new electronic data files.
  • the software can then generate a file or files necessary to program and operate the SDS instrument.
  • the software can then export the file to the SDS instrument. Alternately or additionally, the software can output a printed copy of the protocols and/or parameters used to program the SDS instrument.
  • the SDS instrument can then receive and implement the file and perform the assay or assays using the contents of the assay containers.
  • the SDS instrument can export to a results file containing an electronic copy of data generated by the assay or assays to the software.
  • the software can then save the results file to a disk, such as, for example, a hard drive or CD, for future use.
  • a disk such as, for example, a hard drive or CD, for future use.
  • the customer can paste the printed copy of the protocols and/or parameters in a lab notebook, for example, or can use the information on the printed copy to manually program the SDS instrument.
  • FIGS. 5 a - 5 e are schematic diagrams showing the interaction of components that can comprise, at least in part, a geneous homogeneous reaction mixture, according to various embodiments.
  • primer 52 has annealed to template strand 54 . Replication of the template strand from primer 52 will occur in the 5′ to 3′ direction.
  • Probe 50 including a generic reporter dye R, quencher Q, and minor groove binder MGB, has annealed to the template strand 54 .
  • Arrow 53 shows that as the complementary strand (not shown) is produced from the template strand 54 starting at the forward primer 52 , the complementary strand will meet probe 50 .
  • FIG. 5 b shows the complementary strand 55 as it meets probe 50 a .
  • Polymerase 60 cleaves VIC reporter dye V during the production of complementary strand 55 given that probe 50 a has annealed to the target strand 54 because the target strand 54 and the probe 50 a are completely complementary.
  • FIG. 5 c shows the complementary strand 55 as it meets probe 50 b .
  • Polymerase 60 does not cleave FAM reporter dye F during the production of complementary strand 55 given that probe 50 b has not hybridized with the target strand 54 because of a mismatched base pair at location 64 .
  • FIG. 5 d shows the complementary strand 55 as it meets probe 50 b .
  • Polymerase 60 cleaves FAM reporter dye F during the production of complementary strand 55 given that probe 50 b has annealed to the target strand 54 because the target strand 54 and the probe 50 b are completely complementary.
  • FIG. 5 e shows the complementary strand 55 as it meets probe 50 a .
  • Polymerase 60 does not cleave VIC reporter dye V during the production of complementary strand 55 given that the probe 50 a has not hybridized with the target strand 54 because of a mismatched base pair at location 66 .

Abstract

An assay kit is provided that includes assay reagents stored in a single-tube container, and a data storage medium containing information about the contents of the container. Methods are provided for using the data provided with the kit to direct instruments and/or processes, for example, to control an instrument to perform amplification and/or sequencing reactions.

Description

    CROSS REFERENCE TO RELATED APPLICATIONS
  • This application claims the benefit under 35 U.S.C. §119(e) of prior U.S. Provisional Patent Applications No. 60/352,039, filed Jan. 25, 2002; No. 60/352,356, filed Jan. 28, 2002; No. 60/369,127, filed Apr. 1, 2002; No. 60/369,657, filed Apr. 3, 2002; No. 60/370,921, filed Apr. 9, 2002; No. 60/376,171, filed Apr. 26, 2002; No. 60/380,057, filed May 6, 2002; No. 60/383,627, filed May 28, 2002; No. 60/383,954, filed May 29, 2002; No. 60/390,708, filed Jun. 21, 2002; No. 60/394,115, filed Jul. 5, 2002; and No. 60/399,860, filed Jul. 31, 2002; U.S. Non-Provisional patent application Ser. No. ______ by De La Vega et al., entitled “Methods of Validating SNPs and Compiling Libraries of Assays” [Atty. Docket No. 4797 (5010-022-12)], filed concurrently herewith; and U.S. Non-Provisional patent application Ser. No. ______ by Koehler et al entitled “Methods For Placing, Accepting and Filling Orders For Products And Services” (Atty. Docket No. 9692-000017/US), filed concurrently herewith; all of which are incorporated herein in their entireties by reference.[0001]
  • BACKGROUND
  • Polymerase chain reaction (PCR) is a common scientific technique for amplification of polynucleotides and deoxyribonucleic acid (DNA) complexes. PCR requires the use of several assay reagents as well as a target analyte, such as a target polynucleotide. The target analyte can be contained in a sample and amplified during a PCR process. During the course of the reaction, the target analyte can be amplified many times. Currently, the assay reagents must be gathered and mixed, typically immediately prior to subjecting the sample to PCR. The many assay reagents are typically obtained from multiple sources and typically mixed together on a laboratory bench top in a physical location that commonly houses laboratory equipment necessary to perform PCR. [0002]
  • SUMMARY
  • According to various embodiments, an assay kit is provided that includes: a container containing assay reagents; and a separate data storage medium that contains data about the assay reagents. The assay reagents can be adapted to perform an allelic discrimination or expression analysis reaction when admixed with at least one target polynucleotide. The other reagents can be, for example, components conventionally used for polymerase chain reactions (PCR), and can include non-reactive components. The container can be sealed and can be packaged with the separate data storage medium in a package, for example, in a box. The container can have a machine-readable label that provides information about the contents of the container. [0003]
  • According to various embodiments, the data stored on the data storage medium can include computer-readable code that can be used to adjust, calibrate, direct, set, run, or otherwise control an apparatus, for example, a scientific or laboratory instrument. According to various embodiments, methods are provided wherein the data is used to cause an apparatus to automatically perform a polymerase chain reaction of a target analyte that is mixed with the assay reagents. Methods are also provided whereby the kit is shipped to a customer. [0004]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a top plan segmented view of a plurality of containers in a shipping and storage tray that can be included in a kit, according to various embodiments; [0005]
  • FIG. 2 is a side view of a container of one of the containers shown in FIG. 1; [0006]
  • FIG. 3 is a compact disk that can be included in a kit according to various embodiments; [0007]
  • FIG. 4 is a flowchart outlining a method of use of a container and a data storage medium according to an embodiment; and [0008]
  • FIG. 5 is a schematic diagram of a quenchable dye that can be part of a mixture of reagents according to various embodiments.[0009]
  • It is intended that the specification and examples be considered as exemplary only. The true scope and spirit of the present teachings includes various embodiments. [0010]
  • DESCRIPTION OF VARIOUS EMBODIMENTS
  • According to various embodiments, an assay kit is provided that can include, for example: a container containing assay reagents; and a separate data storage medium that contains data about the assay reagents. The assay reagents can include reagents adapted to perform an allelic discrimination or expression analysis reaction when admixed with at least one target polynucleotide sequence. Reagents can be, for example, reagents used for polymerase chain reaction (PCR) amplification, ligase chain reaction (LCR), oligonucleotide reaction assays (OLA), self-sustaining sequence replication, enzyme kinetic studies, homogeneous ligand binding assays, deoxyribonucleic acid or amino acid sequencing, and/or other chemical or biochemical reaction, and can include non-reactive components. The container can be sealed and can be packaged with the separate data storage medium in a package, for example, in a box. The container can have a machine-readable label that provides information about the contents of the container. [0011]
  • According to various embodiments, the terms “polynucleotide” and “DNA,” as used herein, can include nucleic acid analogs that can be used in addition to or instead of nucleic acids. Examples of nucleic acid analogs includes the family of peptide nucleic acids (PNA), wherein the sugar/phosphate backbone of DNA or RNA has been replaced with acyclic, achiral, and neutral polyamide linkages. For example, a probe or primer can have a PNA polymer instead of a DNA polymer. The 2-aminoethylglycine polyamide linkage with nucleobases attached to the linkage through an amide bond has been well-studied as an embodiment of PNA and shown to possess exceptional hybridization specificity and affinity. An example of a PNA is as shown below in a partial structure with a carboxyl-terminal amide: [0012]
    Figure US20030175774A1-20030918-C00001
  • “Nucleobase” as used herein means any nitrogen-containing heterocyclic moiety capable of forming Watson-Crick hydrogen bonds in pairing with a complementary nucleobase or nucleobase analog, e.g. a purine, a 7-deazapurine, or a pyrimidine. Typical nucleobases are the naturally occurring nucleobases such as, for example, adenine, guanine, cytosine, uracil, thymine, and analogs of the naturally occurring nucleobases, e.g. 7-deazaadenine, 7-deazaguanine, 7-deaza-8-azaguanine, 7-deaza-8-azaadenine, inosine, nebularine, nitropyrrole, nitroindole, 2-aminopurine, 2-amino-6-chloropurine, 2,6-diaminopurine, hypoxanthine, pseudouridine, pseudocytosine, pseudoisocytosine, 5-propynylcytosine, isocytosine, isoguanine, 7-deazaguanine, 2-azapurine, 2-thiopyrimidine, 6-thioguanine, 4-thiothymine, 4-thiouracil, O[0013] 6-methylguanine, N6-methyladenine, O4-methylthymine, 5,6-dihydrothymine, 5,6-dihydrouracil, 4-methylindole, pyrazolo[3,4-D]pyrimidines, “PPG”, and ethenoadenine.
  • “Nucleoside” as used herein refers to a compound consisting of a nucleobase linked to the C-1′ carbon of a sugar, such as, for example, ribose, arabinose, xylose, and pyranose, in the natural β or the α anomeric configuration. The sugar can be substituted or unsubstituted. Substituted ribose sugars can include, but are not limited to, those riboses having one or more of the carbon atoms, for example, the 2′-carbon atom, substituted with one or more of the same or different Cl, F, -R, -OR, -NR[0014] 2 or halogen groups, where each R is independently H, C1-C6 alkyl or C5-C14 aryl. Ribose examples can include ribose, 2′-deoxyribose, 2′,3′-dideoxyribose, 2′-haloribose, 2′-fluororibose, 2′-chlororibose, and 2′-alkylribose, e.g. 2′-O-methyl, 4′-α-anomeric nucleotides, 1′-α-anomeric nucleotides, 2′-4′- and 3′-4′-linked and other “locked” or “LNA”, bicyclic sugar modifications. Exemplary LNA sugar analogs within a polynucleotide can include the following structures:
    Figure US20030175774A1-20030918-C00002
  • where B is any nucleobase. [0015]
  • Sugars can have modifications at the 2′- or 3′-position such as methoxy, ethoxy, allyloxy, isopropoxy, butoxy, isobutoxy, methoxyethyl, alkoxy, phenoxy, azido, amino, alkylamino, fluoro, chloro and bromo. Nucleosides and nucleotides can have the natural D configurational isomer (D-form) or the L configurational isomer (L-form). When the nucleobase is a purine, e.g. adenine or guanine, the ribose sugar is attached to the N[0016] 9-position of the nucleobase. When the nucleobase is a pyrimidine, e.g. cytosine, uracil, or thymine, the pentose sugar is attached to the N1-position of the nucleobase.
  • “Nucleotide” as used herein refers to a phosphate ester of a nucleoside and can be in the form of a monomer unit or within a nucleic acid. “[0017] Nucleotide 5′-triphosphate” as used herein refers to a nucleotide with a triphosphate ester group at the 5′ position, and can be denoted as “NTP”, or “dNTP” and “ddNTP” to particularly point out the structural features of the ribose sugar. The triphosphate ester group can include sulfur substitutions for the various oxygens, e.g. α-thio-nucleotide 5′-triphosphates.
  • As used herein, the terms “polynucleotide” and “oligonucleotide” mean single-stranded and double-stranded polymers of, for example, nucleotide monomers, including 2′-deoxyribonucleotides (DNA) and ribonucleotides (RNA) linked by internucleotide phosphodiester bond linkages, e.g. 3′-5′ and 2′-5′, inverted linkages, e.g. 3′-3′ and 5′-5′, branched structures, or internucleotide analogs. Polynucleotides can have associated counter ions, such as H[0018] +, NH4 +, trialkylammonium, Mg2+, Na+ and the like. A polynucleotide can be composed entirely of deoxyribonucleotides, entirely of ribonucleotides, or chimeric mixtures thereof. Polynucleotides can be comprised of internucleotide, nucleobase and sugar analogs. For example, a polynucleotide or oligonucleotide can be a PNA polymer. Polynucleotides can range in size from a few monomeric units, e.g. 5-40 when they are more commonly frequently referred to in the art as oligonucleotides, to several thousands of monomeric nucleotide units. Unless otherwise denoted, whenever a polynucleotide sequence is represented, it will be understood that the nucleotides are in 5′ to 3′ order from left to right and that “A” denotes deoxyadenosine, “C” denotes deoxycytidine, “G” denotes deoxyguanosine, and “T” denotes thymidine, unless otherwise noted.
  • “Internucleotide analog” as used herein means a phosphate ester analog or a non-phosphate analog of a polynucleotide. Phosphate ester analogs can include: (i) C[0019] 1-C4 alkylphosphonate, e.g. methylphosphonate; (ii) phosphoramidate; (iii) C1-C6 alkyl-phosphotriester; (iv) phosphorothioate; and (v) phosphorodithioate. Non-phosphate analogs can include compounds wherein the sugar/phosphate moieties are replaced by an amide linkage, such as a 2-aminoethylglycine unit, commonly referred to as PNA.
  • “Heterozygous” as used herein means both members of a pair of alleles of a gene are present in a sample obtained from a single source, wherein a gene can have two alleles due to, for example, the fusion of two dissimilar gametes with respect to the gene. [0020]
  • “Heterozygous assay” as used herein means an assay adapted to identify the allelic state of a gene having one or both members of a pair of alleles. [0021]
  • “Homozygous” as used herein means one member of a pair of alleles is present in a sample obtained from a single source, wherein a gene can have one allele due to, for example, the fusion of two identical gametes with respect to the gene. [0022]
  • “Homozygous assay” as used herein means an assay adapted to identify only one of two possible allelic states of a gene having one or both members of a pair of alleles. [0023]
  • As used herein, the terms “customer” and “user” can be interchangeable. [0024]
  • According to various embodiments, the container can contain all assay reagents and components necessary to conduct PCR, with the exception of a target polynucleotide, also referred to as a target nucleic acid sequence or a target DNA. The target polynucleotide can be provided by a user and mixed with the assay reagents or the target polynucleotide can be provided to the user in a second container to be mixed with the assay reagents. For example, the kit can include a container that contains a target polynucleotide and a container that does not contain a target polynucleotide. [0025]
  • According to various embodiments, the container can be a tube, vial, jar, capsule, ampule, or like vessel. The tube can have a removable cap and/or a replaceable cap. The cap can maintain the container sealed such that the container is water-tight and air-tight. The container can be hermetically sealed. The container can be open at a first end and closed at a second end. According to various embodiments, the first end can be tapered, for example, along the length of the container. According to various embodiments, the container can hold a mixture including assay reagents and have a volume of at least about 5 μL. The container can have a volume of about 10 μL or less. The maximum volume of the container can be about 25 μL or less, and according to other embodiments, the volume can be greater than about 25 μL. [0026]
  • According to various embodiments, standardized assay designs are provided for custom assays and/or stock assays, including either universal concentration or uniform thermal cycling parameters, or both, allowing results to be more easily compared with and/or transferred to other researchers and labs. Also, in some embodiments, assays are formulated in a single-[0027] tube 20×mix format that is convenient and easy to use, requiring no preparation or clean-up and providing faster time to results.
  • According to various embodiments, the assay reagents in the container can contain a volume of assay reagents for more than one respective assay. For example, the assay reagents in the container can be divided and transferred into five respective reaction wells, for example, to conduct five identical and/or different assays. For another example, the assay reagents in the container can be removed from the container and aliquoted into ten respective reaction wells. According to various embodiments, the container can contain a sufficient volume of assay reagents to complete at least 1, at least 5, at least 10, or at least 25 assays. [0028]
  • According to various embodiments, the container can have a label that provides information about the contents of the container. For embodiments including a cap, the label can be secured to the container, or to the cap of the container, if desired. The label can comprise a barcode and can comprise a 2-dimensional barcode that can be provided on the container. In addition to or instead of a barcode, the label can include a serial number, a lot number, a date, and/or other identifying or descriptive indicia. The label can identify the reporter dye or dyes in the container. The label can provide sequence information regarding polynucleotide or peptide reagents provided in the container. The label can contain information about the target polynucleotide sequence, including a common or scientific name or gene name for the target polynucleotide or sequence information about a target analyte. The assay kit can be packaged in, for example, a box. Packaging such as a carton or box can instead or additionally be labeled with identifying and/or descriptive indicia and/or coating as described above. [0029]
  • In addition to a human-readable label, for example, an English-language label with the assay name can be located on each tube. In some embodiments, a 2-D barcode can be laser-etched on the bottom of each assay tube and a 1-D barcode can be laser-etched on each 96-tube rack of assays, thereby making the assay tubes and racks machine-identifiable so that the assays are compatible with automation for high throughput applications. [0030]
  • According to various embodiments, the container can contain at least one probe reactive with a target polynucleotide, wherein the probe can include a polynucleotide, a marker compound, for example, a marker dye, a quenchable dye, or a fluorescent reporter dye, a non-fluorescent quencher, a minor groove binder, or a combination thereof. [0031]
  • The probe can include a reporter dye such as VIC or 6-FAM linked to the 5′ end of the polynucleotide. VIC and 6-FAM dye-labeled probes are available from Applied Biosystems, Foster City, Calif. The minor groove binder can increase the melting temperature T[0032] m without increasing the length of the polynucleotide. This can result in greater differences in Tm values between matched and mismatched probes that therefore enables more accurate allelic discrimination. The probe can include a quencher (e.g., a non-fluorescent quencher) linked to the 3′ end of the polynucleotide. The quencher can inhibit fluorescence that can facilitate greater discrimination of reporter dye fluorescence.
  • According to various embodiments, the container can contain two different types of probes, wherein the polynucleotide and the reporter dyes differ. For example, the first type of probe can have a first polynucleotide with a VIC reporter dye attached to the 5′ end of the first polynucleotide and the second type of probe can have a second polynucleotide with a 6-FAM reporter dye attached to the 5′ end of the second polynucleotide and the first and second polynucleotides differ by at least one monomeric unit at the same location in the polynucleotide when the polynucleotides are aligned 5′ to 3′. The dye-labeled probes can be adapted to perform a heterozygous assay or a homozygous assay. [0033]
  • The probe can anneal to a complementary sequence between the forward and reverse primer sites. At the time of annealing, the probe is intact and the proximity of the reporter dye to the quencher can result in suppression of fluorescence of the reporter dye. A polymerase can cleave a reporter dye only when the probe has completely, mostly, or substantially hybridized to the target polynucleotide sequence. When the reporter dye is cleaved from the probe, the relative fluorescence of the reporter dye increases. The increase in relative fluorescence can only occur if the amplified target polynucleotide sequence is complementary, mostly complementary, or substantially complementary to the probe. Therefore, the fluorescent signal generated by PCR amplification can indicate which alleles are present in a sample. Mismatches between a probe and a target polynucleotide sequence can reduce efficiency of probe hybridization and/or a polymerase can be more likely to displace a mismatched probe without cleaving it and therefore not produce a fluorescent signal. For example, if one of two possible reporter dyes fluoresce during an assay, then the presence of a homozygous gene is indicated. For further example, if both possible reporter dyes fluoresce during an assay, then the presence of a heterozygous gene is indicated. [0034]
  • According to various embodiments, the container can contain at least one primer, wherein the primer can comprise a sequence that is shorter than the target polynucleotide. The primer can comprise a polynucleotide and/or a minor groove binder. The primer can comprise a sequence that is complimentary to, or mostly complimentary to, the target polynucleotide. For example, the primer can be at least 90% homologous to a corresponding length of the target polynucleotide, at least 80% homologous to a corresponding length of the target polynucleotide, at least 70% homologous to a corresponding length of the target polynucleotide, or at least 50% homologous to a corresponding length of the target polynucleotide. [0035]
  • According to various embodiments, the container can contain a thermostable DNA polymerase, such as, for example, thermos aquaticus (Taq), and at least 4 embodiments of a deoxyribonucleic acid (e.g., adenosine, tyrosine, cytosine, and guanine). The polymerase can be, for example, AMPLITAQ GOLD, available from Applied Biosystems, Foster City, Calif. According to various embodiments, the container can container components of a fluorogenic 5′ nuclease assay or other assay reagents that utilize 5′ nuclease chemistry, for example, TAQMAN minor groove binder probes, available from Applied Biosystems, Foster City, Calif. Some or all of the above-listed components can be replaced by or used with commercially-available products, for example, buffers or AMPLITAQ GOLD PCR MASTER MIX (Applied Biosystems, Foster City, Calif.). [0036]
  • According to various embodiments, the assay kit can further include a target polynucleotide in the first or another container, for example, as can be used to prepare a positive control. The assay kit can include more than one container and an Assay Information File (AIF) and/or Electronic Data Sheet (EDS) can be provided on the data storage medium and can contain information about the containers. For example, an AIF or EDS can contain information about 96 containers or 384 containers. [0037]
  • According to various embodiments, a multi-well plate can also be provided in the kit and can include, for example, 96 or 384 positions for container placement. A plate can be substantially rectangular with an optional integrated structural feature for plate orientation. A plate can have a plurality of wells. The assay kit can include a plate adapted to hold a plurality of containers or tubes. The plate can be of unitary construction. One or more containers can be integrated into a single plate, and the plate can have a plurality of containers in physical contact with each other. For example, the plate can be of unitary construction and have 96 containers in the form of receptacles. For further example, the plate can be of unitary construction and have 384 containers. [0038]
  • Assays may be delivered with certain sequence information. For example, some sequence context information (e.g., forward primer location in the RefSeq sequence) can denote which exon-exon junction the assay covers so that users can get a sense of where the assay is positioned in the transcript. More information can be provided, as desired. [0039]
  • For example, according to various embodiments, data can have the following columns (non-limiting examples are listed in paratheticalls following the item): customer name (assigned by the supplier); order number (assigned by the supplier, in some configurations, and can correspond to a number on a 1-D bar code on the plate); ship date (date shipped by the supplier); set ID (an assay name created from record information in the requestor's submission file, including record name and target site name from a target site coordinate; if the sequence record submitted contained multiple target sites, the value of the Set ID can be used to determine which site was used to create the assay); set No. (may be used for internal quality control by the supplier); plate ID (assigned by the supplier, can include the order number value, and can appear on the plate rack as the 1-D bar code); vial ID (a 2-D bar code number can be attached to the bottom of each tube; entry in the datasheet may have leading zeros dropped in some configurations); well location (location of assay tube in the plate rack); line item (may be used for internal quality control by the supplier); VIC probe name (may be used for internal quality control by the supplier); VIC probe sequence (5′ to 3′ sequence of the probe labeled with VIC dye; in some configurations, the 3′ non-fluorescent quencher-minor groove binder (NFQ-MGB) may not be listed but is present on the probe); VIC (μM) concentration (probe concentration); line item (may be used for internal quality control by the supplier); 6-FAM probe name (may be used for internal quality control by the supplier); 6-FAM probe sequence (5′ to 3′ sequence of the probe labeled with 6-FAM dye; in some configurations, the 3′ NFQ-MGB may not be listed but is present on the probe); 6-FAM (μM) concentration (probe concentration); line item (may be used for internal quality control by the supplier); forward primer name (may be used for internal quality control by the supplier); forward primer sequence; forward (μM) primer concentration; line item (may be used for internal quality control by the supplier); reverse primer name (may be used for internal quality control by the supplier); reverse primer sequence; reverse (μM) primer concentration; and/or part number (the part number ordered by the requester). [0040]
  • The shipped worksheet can be provided to enable a user of the assays to determine that the tubes are in the same positions in the plate rack as when the assays were shipped. For example, according to various embodiments, the following columns can appear in the shipped worksheet: position (position in the plate); and/or vial ID (a 2-D bar code number that can be attached to the bottom of the tube; in some configurations, leading zeros are dropped). [0041]
  • According to various embodiments, the assay kit can be shipped to a customer. The data storage medium can be shipped to the customer along with, concurrent to, separately, previously, or subsequently to shipment of the container and the contents of the container. Alternatively, or additionally, data can be transferred electronically to the customer. The data can be sent to the customer by electronic mail. The customer can retrieve or download the information over a computer network, such as, for example, the Internet, a Wide Area Network, a Local Area Network, or a Virtual Private Network. The customer can retrieve the data using a file transfer protocol or by a hypertext transfer protocol. The protocol can be secured using, for example, 128 bit encryption. [0042]
  • According to various embodiments, the manufactured assays are shipped as homogenous assays in a single tube format. For example, in at least some embodiments, a single-tube, ready to use format is provided that is suitable for immediate use on an ABI PRISM® Sequence Detection System (SDS) instrument for one or more applications. [0043]
  • Data stored on the data storage medium can include information about a variety of items, for example, a stock number, an assay ID number, a plate number, a well location, a gene symbol or name, a category ID or name, a group ID or name, a chromosome number, a cytogenetic band identification, an NCBI gene reference, an NCBI SNP reference, a minor allele frequency, a minor allele frequency of a particular population, an SNP type, a context sequence, a reporter dye identification, barcode information, or a combination thereof. The context sequence can include, for example, up to 20 bases, more than 20 bases, more than 30 bases, or more than 40 bases. The data stored on the data storage medium can include information about some of the previously-mentioned items, all of the previously-mentioned items, or none of the previously-mentioned items. Furthermore, the information can include more information than that information listed above and/or other identifying or descriptive indicia. [0044]
  • According to various embodiments, the data storage medium can be separate from the container or can be affixed to the container. The data storage medium can be a label attached to the container, for example, with a pressure sensitive adhesive or other glue. The container or cap can serve as the data storage medium and the data can be printed, etched, inscribed, or otherwise encoded on a surface of the container or cap. The data storage medium can include an optically detectable code and/or the data storage medium can be a 2-dimensional barcode. [0045]
  • According to various embodiments, the data can be stored on the data storage medium in electronic format. The data storage medium can be a compact disk (CD). The information can be contained in an Assay Information File (AIF) and/or the Assay Information File can be in the form of an ascii-compatible text file. The data can be contained in an Electronic Data Sheet (EDS) and/or the EDS can be in the form of an ascii-compatible text file. The EDS can contain information that links container identification information, such as, for example, the information contained on a 2-dimensional barcode on the container, to assay identification information. The link can be to assay information contained in, for example, an Assay Information File. The AIF, the EDS, or other computer-readable data or code contained or stored on the data storage medium can be adapted to control an apparatus such as a scientific or laboratory instrument, for example, a thermal cycler, or sequence detection system. [0046]
  • According to various embodiments, the data storage medium can, in addition or in the alternative, contain executable code. The executable code can be in the form of stand-alone software, updates to stand-alone software, or modules to third-party software. The software can be adapted to run on an operating system that controls an SDS instrument, such as, for example, UNIX. The software can include computer code written in assembly language or machine language. The software can be transferred to the SDS instrument by computer and can be saved onto a storage device in the SDS instrument, loaded into a memory device of the SDS instrument, incorporated into previously-loaded software on the SDS instrument, or can be overwritten onto previously-loaded software on the SDS instrument. The storage device can be a hard drive or optical drive. The memory device can be random access memory (RAM) or an erasable, programmable read only memory (EPROM) chip. The software can be provided to a customer on a data storage medium or can be transferred to the customer over a computer network. [0047]
  • According to various embodiments, an Assay Information File (AIF) or Electronic Data Sheet (EDS) can be provided with an assay or assays. The AIF and/or EDS can be, in some embodiments, electronic files or data electronically stored on a data storage medium. The files or data can contain, for example, information on one or more assays, information on one or more polynucleotide sequences, an alphanumeric sequence representing a polynucleotide sequence, or the like. Alternatively, or in addition, a print copy or a printout of the AIF, EDS, and/or information in the AIF and/or EDS can be provided. [0048]
  • According to various embodiments, a printed copy of the AIF and/or EDS can also be provided and can contain information about each assay. This information may include, among other things, the position of each assay in the plate rack. Some embodiments provide, either in place of, or in addition to the printed copy of the AIF and/or EDS, a CD-ROM with one or more data files recorded thereon. The data may include any or all of the following files, and may include other files as well: an electronic assay workbook, including data sheet(s) and shipped worksheet(s); an electronically readable and/or printable copy of instructions for SNP assay protocol for ordering by design; an electronically readable and/or printable copy of protocols for submitting requests; and/or an electronically readable copy of a product insert. [0049]
  • According to various embodiments, a data sheet and/or an electronic assay workbook is provided with custom assays. In some embodiments, an electronic assay workbook is included with each order of up to 92 assays. The workbook file name can include the number on a bar code for easy correlation. The workbook can contain two worksheets, namely, a “data sheet” worksheet and a “shipped” worksheet. The workbook can be a spreadsheet file, such as a MICROSOFT EXCEL spreadsheet software file, that may contain macros and/or be password protected. Cells of the workbook can be copied and pasted into a new worksheet and modified in the new worksheet. A printed copy of the data from the electronic file may be included with a shipment of assays ordered, for example, by design. The data can include a correlation of the 2-D barcodes on the tubes to the corresponding assay names and primer and probe specific information. [0050]
  • According to various embodiments, data included with an order can include at least some of the following information: an identification of the assay in each tube; assay names; which target site was used, if the requester submitted a sequence record that included more than one target site; locations of each tube in the assay rack; sequences of the primers and probes; and concentrations (μM) of primers and probes. Other configurations can necessarily include all of this information and may include more information. [0051]
  • According to various embodiments, a computer program, comprised of lines of machine-readable and/or executable computer code, can obtain data contained in the AIF, EDS, or in another data file, and use the data to control a scientific or laboratory instrument. For example, a microcomputer-based software program can be provided that can load computer-readable data from an AIF or EDS. The AIF or EDS can be stored, for example, on a compact disk that can be shipped to a user along with, concurrent to, previous to, or subsequent to shipping and providing the at least one container of the assay kit. According to various embodiments, the software program can configure, direct, or operate an instrument that can perform PCR, sequencing, and/or sequence detection, for example, an Applied Biosystems 7900HT Sequence Detection System (SDS). The software program can control, for example, an instrument, to perform PCR, sequencing, and/or sequence detection, without human intervention. The SDS can directly operate and run without human interaction The same or a different software program can perform basecalling of detected sequence data. [0052]
  • According to various embodiments, the kit can include a software program stored on the data storage medium or stored separately on a second data storage medium, for example, a CD. The software program can build an internal assay information database from AIF or EDS files and/or generate plate information adapted to control, at least in part, an SDS instrument. The software can deliver the plate information to the SDS. The software program can flag or note problems with the plate information or plate setup data. The software program can generate an activity log file. The software can detect new plate information setup files, new AIF files, new EDS files, or a combination thereof. The software can import data generated by the customer. The software program can add to, modify, or delete data from an AIF or EDS. The software program can control or direct an SDS instrument to perform, for example, PCR, sequencing, sequence detection, or a combination thereof. The software program can control an SDS instrument to perform PCR, sequencing, or sequence detection using a protocol obtained from an AIF or EDS. [0053]
  • According to various embodiments, the software can receive data from an instrument, for example, from a real-time PCR or SDS instrument, wherein the data is generated during the course of, for example, PCR, sequencing, or sequence detection. An SDS data file can be generated by an SDS instrument and can be transmitted to the software program. The SDS data file can contain information generated by an SDS instrument, or information from an AIF or EDS stored on the data storage medium. The SDS data file can contain error codes or error information generated by the SDS instrument as a result of problems with the SDS instrument, the AIF, and/or the EDS. The data file can include error codes related to, for example, failure to detect at least one fluorescent probe or failure of a component of the SDS instrument, such as a heating element. The SDS instrument can send a log file containing, for example, information about AIF or EDS files transmitted from the software program. A detector list can be generated from an AIF or an EDS and saved in a format suitable for input to a detector manager, such as, for example, an ascii-compatible format. [0054]
  • According to various embodiments, the software can save an AIF, EDS, and/or SDS data file, or other file in separate, respective folders on a data storage device, for example, on a microcomputer. The microcomputer can include, for example, a hard drive, an optical drive, or both. The software program can remain in the memory of a microcomputer before, during, or after transmission of a data file to or from the software program. The software program can continuously monitor data on a microcomputer for new or modified AIF, EDS, and/or SDS data files. [0055]
  • According to various embodiments, a manual method can be used by a customer or user of the assays to validate each tube position in the rack plate. The rack plate position and assay name on the tube label can be compared with the values in the well location and set ID columns of the data. This “validation” is different from the validation of assays, in that validation of each tube position in a plate rack is performed by the user, and merely confirms that the tubes are in positions matching the “shipped” worksheet. If the tubes are not in the correction position, they may be rearranged to match the worksheet. The operational quality of the assays contained within the tubes is validated at the supplier's factory. [0056]
  • According to various embodiments, an automated method can be used by a customer to validate each tube position in the rack plate. This method can include scanning the plate and tubes using a 2-D bar code reader, and executing a plate validation spreadsheet macro (for example, a MICROSOFT EXCEL spreadsheet software macro). To scan the plate and tubes, the plate rack can be placed on the 2-D bar code reader in a standard orientation. For example, tube position “A1” is placed in the top left corner of the reader. The 1-D bar code on the plate rack can then be scanned. The bar code reader can be configured, if necessary, to read positions in one column and to read bar codes in a column next to the positions column. Next, the plate rack is scanned and the results are saved to a director that can be accessed from the computer containing the electronic file. In some configurations, the scanning results are saved as a tab-delimited file. [0057]
  • According to various embodiments, to validate, the “shipped” worksheet can be opened in the spreadsheet and, with macros enabled, the validation macro can be run. In some embodiments utilizing MICROSOFT EXCEL spreadsheet software, the validation is performed by opening the electronic workbook, clicking a mouse on a “shipped” tab to view the worksheet containing the validation macro, clicking on the “validate” button to start the plate validation macro, and, when an “import plate scan” dialog box is presented, selecting “browse” to locate the file from the 2-D bar code scan. After “browse” is selected, the file that resulted from the 2-D bar code scan is selected and imported into a new worksheet, which, in some embodiments, is called “received”. The macro can then compare each bar code and its position in the plate rack with the corresponding bar code in the “shipped” worksheet (for example, a value in the “Vial: ID” column). The macro then enters the result in a “validation” column in the “shipped” worksheet. According to various embodiments, the results for each entry may either be “OK” (or any entry understood as indicating a match) or “ERROR” (or any other entry understood as indicating a non-match). A “shipment validation” dialog box can then alert that the validation is complete, and the user clicks “OK” to dismiss the dialog box. [0058]
  • Plate validation errors indicate that the tubes are not in the same position as they were shipped by the supplier to the requester. The user can resolve plate validation errors by rearranging the tubes to match the “shipped” worksheet. The user can then rescan the plate and execute the validation macro again to validate the plate. [0059]
  • According to various embodiments, an assay kit can be provided that includes at least one assay for allelic discrimination or expression analysis of genomic material. An information source can be provided that has at least one member of the group consisting of an electronic data sheet, an assay information file, and at least one printed datasheet and combinations thereof. The assay can be a SNP assay or a gene expression assay. The assay can be provided in a single tube. [0060]
  • According to various embodiments, the assay can comprise at least one probe and two primers. The assay can be a SNP assay comprising one probe for each of two alleles and two primers. According to various embodiments, the probe can have at least one fluorophore and at least one fluorescence quencher. The fluorescence quencher can be non-fluorescent fluorescence quencher. The probe can have at least one minor groove binder. The assay can have PCR reagents or RT-PCR reagents. The assay can have universal master mix, where the universal master mix has at least one salt, a buffer, and a DNA polymerase. [0061]
  • According to various embodiments, the single tube can have a bar code label. The bar code label can be a two-dimensional bar code label. The single tube can have a human-readable assay number. The kit can be comprised of a plurality of assays, each of which is in a single tube, thereby constituting a plurality of tubes. The plurality of tubes can be contained in a rack and the rack can have a bar-code identification. The kit can also have at least one datasheet containing information on the assay. The kit can have at least one machine-readable medium containing information on the assay. The at least one machine-readable medium can be at least one datasheet containing information on the assay. The machine-readable medium can be a compact disk. [0062]
  • Referring to the drawing figures, FIG. 1 is a plan sectional view of an embodiment of an assay kit having [0063] several containers 10 that are held in place for shipping in a tray 12. A 2-dimensional barcode 14 is located on the top side of a container cap 16. The 2-dimensional barcode 14 is adapted to be machine readable. A serial number 18 is located next to the 2-dimensional barcode 14. The serial number 18 is printed in Arabic numerals.
  • FIG. 2 is a side view of one of the [0064] containers 10 shown in FIG. 1. The container 10 has a 2-dimensional barcode 14 and a serial number 18 printed on a cap 16 for the container 10. The cylindrical body 20 of the container 10 is adapted to hold a mixture of assay reagents and is adapted to fit into a tray 12 for shipping and storage.
  • FIG. 3 is a [0065] compact disk 22 that can be included in an assay kit according to various embodiments, and can be provided to a user along with a container (not shown in FIG. 3) containing a mixture including assay reagents.
  • FIG. 4 is a flowchart outlining a method of use of a container and a data storage medium according to an embodiment. A customer can request one or more assays from a supplier. The customer receives from the supplier a CD containing an electronic data file and an assay container or containers, and loads the CD into a CD reader of a computer (e.g., a microcomputer) having software that can communicate with an SDS instrument, for example, an ABI 7900HT system. The software on the microcomputer detects the new electronic data file on the CD and loads the electronic data file into memory. The software can read the contents of the electronic data file and can: build an internal assay information database from the electronic data file; flag problems with any file necessary to run or operate the SDS instrument; generate or update an activity log; and monitor for any new electronic data files. The software can then generate a file or files necessary to program and operate the SDS instrument. The software can then export the file to the SDS instrument. Alternately or additionally, the software can output a printed copy of the protocols and/or parameters used to program the SDS instrument. The SDS instrument can then receive and implement the file and perform the assay or assays using the contents of the assay containers. Upon completion of the assay or assays, the SDS instrument can export to a results file containing an electronic copy of data generated by the assay or assays to the software. The software can then save the results file to a disk, such as, for example, a hard drive or CD, for future use. If desired, the customer can paste the printed copy of the protocols and/or parameters in a lab notebook, for example, or can use the information on the printed copy to manually program the SDS instrument. [0066]
  • FIGS. 5[0067] a-5 e are schematic diagrams showing the interaction of components that can comprise, at least in part, a geneous homogeneous reaction mixture, according to various embodiments. In FIG. 5a, primer 52 has annealed to template strand 54. Replication of the template strand from primer 52 will occur in the 5′ to 3′ direction. Probe 50, including a generic reporter dye R, quencher Q, and minor groove binder MGB, has annealed to the template strand 54. Arrow 53 shows that as the complementary strand (not shown) is produced from the template strand 54 starting at the forward primer 52, the complementary strand will meet probe 50. FIG. 5b shows the complementary strand 55 as it meets probe 50 a. Polymerase 60 cleaves VIC reporter dye V during the production of complementary strand 55 given that probe 50 a has annealed to the target strand 54 because the target strand 54 and the probe 50 a are completely complementary. FIG. 5c shows the complementary strand 55 as it meets probe 50 b. Polymerase 60 does not cleave FAM reporter dye F during the production of complementary strand 55 given that probe 50 b has not hybridized with the target strand 54 because of a mismatched base pair at location 64. FIG. 5d shows the complementary strand 55 as it meets probe 50 b. Polymerase 60 cleaves FAM reporter dye F during the production of complementary strand 55 given that probe 50 b has annealed to the target strand 54 because the target strand 54 and the probe 50 b are completely complementary. FIG. 5e shows the complementary strand 55 as it meets probe 50 a. Polymerase 60 does not cleave VIC reporter dye V during the production of complementary strand 55 given that the probe 50 a has not hybridized with the target strand 54 because of a mismatched base pair at location 66.
  • Those skilled in the art can appreciate from the foregoing description that the broad teachings herein can be implemented in a variety of forms. Therefore, while the present teachings have been described in connection with various embodiments and examples, the scope of the present teachings should not be so limited [0068]

Claims (81)

What is claimed is:
1. An assay kit comprising:
a container, the container containing a mixture having reagents adapted to perform an allelic discrimination or expression analysis reaction when admixed with at least one target polynucleotide sequence, and
a data storage medium containing data about the contents of the first container.
2. The assay kit of claim 1, further comprising a second container that contains assay reagents.
3. The assay kit of claim 1, wherein the container has a machine-readable label that provides information about the contents of the container.
4. The assay kit of claim 1, further comprising at least one first probe, wherein the at least one first probe has a first marker dye.
5. The assay kit of claim 1, wherein the container is sealed.
6. The assay kit of claim 1, wherein the kit further comprises a target polynucleotide.
7. The assay kit of claim 1, wherein the reagents utilize fluorogenic 5′ nuclease chemistry during the performance of the reaction.
8. The assay kit of claim 1, wherein the mixture further comprises a DNA polymerase, one or more polynucleotide monomers, at least one salt, and a buffer.
9. The assay kit of claim 8, wherein the polynucleotide monomers are peptide nucleic acids.
10. The assay kit of claim 1, wherein the container is a tube.
11. The assay kit of claim 5, wherein the sealed container is sealed with a removable cap.
12. The assay kit of claim 1, wherein the data storage medium is a compact disk (CD) and the data is electronically formatted.
13. The assay kit of claim 1, wherein the data includes sequence information about at least one of at least one first probe and at least one primer.
14. The assay kit of claim 4, wherein the data includes information about the first marker dye.
15. The assay kit of claim 4, wherein the data includes information that is capable of controlling at least one scientific laboratory instrument.
16. The assay kit of claim 15, wherein the at least one instrument is an instrument designed to perform at least one of a polymerase chain reaction and a polynucleotide sequencing reaction.
17. The assay kit of claim 15, wherein the data storage medium is a compact disk (CD) and the data is electronically formatted.
18. The assay kit of claim 1, wherein the data storage medium contains a software program that can be utilized with data contained on the data storage medium to control at least one scientific or laboratory instrument.
19. The assay kit of claim 18, wherein the software program is adapted to receive output data from at least one scientific or laboratory instrument.
20. The assay kit of claim 1, further comprising a second data storage medium, and the second data storage medium contains a software program that can be utilized to control at least one scientific or laboratory instrument.
21. The assay kit of claim 20, wherein the software program is adapted to receive output data from at least one instrument.
22. The assay kit of claim 1, wherein the data storage medium is separate from the container.
23. The assay kit of claim 1, wherein the data storage medium is affixed to the container.
24. The assay kit of claim 23, wherein the data storage medium includes an optically detectable code.
25. The assay kit of claim 23, wherein the data storage medium is the form of a 2-dimensional barcode.
26. The assay kit of claim 1, wherein the data storage medium is etched in the container.
27. A method of performing an assay, comprising:
providing an assay kit according to claim 1, using the data to control an instrument to process the assay reagents, and performing an assay.
28. The method of claim 27, further comprising processing the data with a software program to control the instrument.
29. A method comprising:
providing the assay kit of claim 1; and
shipping the assay kit to a customer.
30. The method of claim 29, wherein the assay kit comprises reagents for conducting a homogeneous assay.
31. A genetic-analysis kit, comprising:
a first container;
a reaction mixture held in the first container, the reaction mixture being adapted for allelic discrimination or expression analysis;
a data storage medium including information in electronic form thereon, the information pertaining at least in part to the reaction mixture; and
a second container holding the first container and the data storage medium for transport as a unit.
32. The kit of claim 31, wherein the first container comprises a tube.
33. The kit of claim 31, wherein the second container comprises a package.
34. The kit of claim 31, wherein the data storage medium comprises a disk.
35. The kit of claim 34, wherein the disk comprises a removable disk.
36. The kit of claim 31, wherein the reaction mixture comprises a homogeneous reaction mixture.
37. The kit of claim 36, wherein the homogeneous reaction mixture comprises components for conducting a fluorogenic 5′ nuclease assay.
38. The kit of claim 31, wherein the information is comprised, at least in part, of American Standard Code for Information Interchange (ascii)-formatted text.
39. The kit of claim 31, wherein the data storage medium further includes machine-readable code thereon.
40. A method for facilitating genetic analysis:
receiving from a user a request for one or more genetic-analysis assays; and
providing to the customer (i) the one or more assays, with each assay being provided in a single-tube format, and (ii) information relating to the one or more assays, with the information being in electronic form.
41. The method of claim 40, wherein the one or more assays each comprises a homogeneous reaction mixture.
42. The method of claim 41, wherein the homogeneous reaction mixture comprises components for conducting a fluorogenic 5′ nuclease assay.
43. The method of claim 40, wherein the information is provided on a disk.
44. The method of claim 43, wherein the disk is a removable disk.
45. The method of claim 40, wherein the information is provided via a computer network.
46. The method of claim 45, wherein the information is transmitted to the customer via electronic mail.
47. The method of claim 45, wherein the information is provided via a file transfer protocol (FTP).
48. The method of claim 40, wherein the information is comprised, at least in part, of ascii-formatted text.
49. The method of claim 40, wherein at least one of the one or more assays and the information are shipped to the customer together in a single package.
50. A method for genetic analysis, comprising:
requesting a plurality of assay mixtures for genetic analysis from a supplier;
receiving from the supplier (i) the plurality of assay mixtures, and (ii) information, in electronic form, pertaining to each assay mixture;
transferring at least a portion of the electronic information to a computer system adapted for electronic communication with a thermal cycler; and
employing the computer system and at least a portion of the information, instructing the operation of the instrument, whereby each of the assay mixtures is analyzed.
51. The method of claim 50, wherein each of the plurality of assays comprises a homogeneous reaction mixture.
52. The method of claim 51, wherein the homogeneous reaction mixture comprises components for conducting a fluorogenic 5′ nuclease assay.
53. The method of claim 50, wherein the information is provided on a removable disk.
54. The method of claim 50, wherein the thermal cycler is configured to perform a real-time polymerase chain reaction.
55. The method of claim 50, wherein the information is provided via a computer network.
56. The method of claim 55, wherein the information is transmitted by the supplier via electronic mail.
57. The method of claim 55, wherein the information is downloaded by the customer from a server.
58. The method of claim 50, wherein the information is comprised, at least in part, of American Standard Code for Information Interchange (ASCII)-formatted text.
59. The method of claim 50, wherein at least one of the plurality of assays and the information are shipped to the user together in a single package.
60. The method of claim 50, wherein each of the plurality of assay mixtures is contained in a single tube.
61. The method of claim 50, wherein the requesting step is carried out via the Internet.
62. A method for facilitating genetic analysis, comprising:
receiving a request for a plurality of assay mixtures for genetic analysis from a customer; and
supplying to the user (i) the plurality of assay mixtures, (ii) information, in electronic form, pertaining to each assay mixture, and (iii) a program storage device readable by a computer system, embodying a program of instructions executable by the computer system to perform method steps for genetic analysis, the method steps comprising (a) transferring at least a portion of the electronic information to a memory of the computer system, (b) employing at least a portion of the information, generating instructions for the operation of a thermal cycler adapted to perform real-time polymerase chain reaction, and (c) sending the instructions to the thermal cycler whereby the thermal cycler acts upon the assay mixtures.
63. The method of claim 62, wherein the plurality of assay mixtures and the information is supplied to the user together, at the same time.
64. The method of claim 62, wherein the information is provided on a removable disk.
65. The method of claim 64, wherein the removable disk comprises a compact disk (CD).
66. The method of claim 62, wherein the information is provided via a computer network.
67. The method of claim 62, wherein each of the plurality of assay mixtures comprises a homogeneous reaction mixture.
68. The method of claim 67, wherein each homogeneous reaction mixture comprises a fluorogenic 5 nuclease assay.
69. The method of claim 62, wherein each of the plurality of assay mixtures is contained in a single tube.
70. The method of claim 62, wherein the program storage device comprises a removable disk.
71. The method of claim 62, further comprising providing a web site configured for receiving requests from customers for assay mixtures for genetic analysis.
72. A program storage device readable by a computer system, embodying a program of instructions executable by the computer system for genetic analysis, the method steps comprising:
(i) uploading electronic information relating to a plurality of assay mixtures from a data storage device to the computer system,
(ii) employing the information, generating a file containing instructions for operation of a thermal cycler; and
(iii) tranferring the file to the thermal cycler for implementation.
73. The device of claim 72, wherein the method steps further comprise:
monitoring for electronic information ready for uploading.
74. The device of claim 72, wherein the method steps further comprise:
receiving a results file from the thermal cycler, and causing the results file to be saved.
75. The device of claim 72, wherein the method steps further comprise:
building an assay information database.
76. The device of claim 72, wherein the method steps further comprise:
generating plate documents and providing the plate documents in the file for transfer to the thermal cycler.
77. The device of claim 72, wherein the method steps further comprise:
generating or updating an activity log.
78. The device of claim 72, wherein the method steps further comprise:
outputting the instructions to a printer for printing.
79. The device of claim 72, wherein the method steps further comprise:
determining errors in the information or instructions that could adversely impact analysis of the assay mixtures.
80. The device of claim 72, wherein the data storage device is a removable disk.
81. The device of claim 72, wherein the thermal cycler is adapted to perform a real-time polymerase chain reaction.
US10/335,690 2002-01-25 2003-01-02 Single-tube, ready-to-use assay kits, and methods using same Abandoned US20040063109A2 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
US10/335,690 US20040063109A2 (en) 2002-01-25 2003-01-02 Single-tube, ready-to-use assay kits, and methods using same
JP2003564261A JP2005515785A (en) 2002-01-25 2003-01-27 Single tubes, off-the-shelf assay kits and methods for their use
PCT/US2003/002238 WO2003064670A1 (en) 2002-01-25 2003-01-27 Single-tube, ready-to-use assay kits and methods using same
EP03707531A EP1468103A4 (en) 2002-01-25 2003-01-27 Single-tube, ready-to-use assay kits and methods using same
AU2003209375A AU2003209375A1 (en) 2002-01-25 2003-01-27 Methods of validating snps and compiling libraries of assays
EP03707532A EP1483405A4 (en) 2002-01-25 2003-01-27 METHODS OF VALIDATING SNPs AND COMPILING LIBRARIES OF ASSAYS
PCT/US2003/002240 WO2003065000A2 (en) 2002-01-25 2003-01-27 METHODS OF VALIDATING SNPs AND COMPILING LIBRARIES OF ASSAYS
US10/404,640 US20040072195A1 (en) 2002-01-25 2003-04-01 Single-tube, ready-to-use assay kits, and methods using same
JP2006183943A JP2006294059A (en) 2002-01-25 2006-07-03 Single tube, ready-to-use assay kit and method using same
US12/404,674 US20090239290A1 (en) 2002-01-25 2009-03-16 Single-tube, ready-to-use assay kits, and methods using same
US12/408,870 US20090239233A1 (en) 2002-01-25 2009-03-23 Single-tube, ready-to-use assay kits, and methods using same

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US35203902P 2002-01-25 2002-01-25
US35235602P 2002-01-28 2002-01-28
US36912702P 2002-04-01 2002-04-01
US36965702P 2002-04-03 2002-04-03
US37092102P 2002-04-09 2002-04-09
US37617102P 2002-04-26 2002-04-26
US38005702P 2002-05-06 2002-05-06
US38362702P 2002-05-28 2002-05-28
US38395402P 2002-05-29 2002-05-29
US39070802P 2002-06-21 2002-06-21
US39411502P 2002-07-05 2002-07-05
US39986002P 2002-07-31 2002-07-31
US10/335,690 US20040063109A2 (en) 2002-01-25 2003-01-02 Single-tube, ready-to-use assay kits, and methods using same

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US10/404,640 Continuation-In-Part US20040072195A1 (en) 2002-01-25 2003-04-01 Single-tube, ready-to-use assay kits, and methods using same
US12/404,674 Continuation US20090239290A1 (en) 2002-01-25 2009-03-16 Single-tube, ready-to-use assay kits, and methods using same

Publications (2)

Publication Number Publication Date
US20030175774A1 true US20030175774A1 (en) 2003-09-18
US20040063109A2 US20040063109A2 (en) 2004-04-01

Family

ID=27671405

Family Applications (7)

Application Number Title Priority Date Filing Date
US10/334,793 Abandoned US20040018506A1 (en) 2002-01-25 2003-01-02 Methods for placing, accepting, and filling orders for products and services
US10/335,690 Abandoned US20040063109A2 (en) 2002-01-25 2003-01-02 Single-tube, ready-to-use assay kits, and methods using same
US10/502,761 Abandoned US20050282162A1 (en) 2002-01-25 2003-01-27 Methods of validating snps and compiling libraries of assays
US12/015,143 Abandoned US20080228589A1 (en) 2002-01-25 2008-01-16 Methods For Placing, Accepting, And Filling Orders For Products and Services
US13/458,879 Expired - Lifetime US9464320B2 (en) 2002-01-25 2012-04-27 Methods for placing, accepting, and filling orders for products and services
US15/256,827 Expired - Lifetime US10689692B2 (en) 2002-01-25 2016-09-06 Methods for placing, accepting, and filling orders for products and services
US16/894,028 Abandoned US20200392571A1 (en) 2002-01-25 2020-06-05 Methods for placing, accepting, and filling orders for products and services

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US10/334,793 Abandoned US20040018506A1 (en) 2002-01-25 2003-01-02 Methods for placing, accepting, and filling orders for products and services

Family Applications After (5)

Application Number Title Priority Date Filing Date
US10/502,761 Abandoned US20050282162A1 (en) 2002-01-25 2003-01-27 Methods of validating snps and compiling libraries of assays
US12/015,143 Abandoned US20080228589A1 (en) 2002-01-25 2008-01-16 Methods For Placing, Accepting, And Filling Orders For Products and Services
US13/458,879 Expired - Lifetime US9464320B2 (en) 2002-01-25 2012-04-27 Methods for placing, accepting, and filling orders for products and services
US15/256,827 Expired - Lifetime US10689692B2 (en) 2002-01-25 2016-09-06 Methods for placing, accepting, and filling orders for products and services
US16/894,028 Abandoned US20200392571A1 (en) 2002-01-25 2020-06-05 Methods for placing, accepting, and filling orders for products and services

Country Status (6)

Country Link
US (7) US20040018506A1 (en)
EP (2) EP1706826A4 (en)
JP (3) JP2005516300A (en)
AU (1) AU2003209375A1 (en)
CA (1) CA2474482A1 (en)
WO (3) WO2003065146A2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100285986A1 (en) * 2007-11-02 2010-11-11 Friedrich Menges Single-step multiplex immunoassay
US20110175343A1 (en) * 2005-01-31 2011-07-21 Pipe Maintenance, Inc. Identification system for drill pipes and the like
US9464320B2 (en) 2002-01-25 2016-10-11 Applied Biosystems, Llc Methods for placing, accepting, and filling orders for products and services
US10677810B2 (en) 2016-10-07 2020-06-09 Brooks Automation, Inc. Sample tube and method

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8137619B2 (en) 1997-08-11 2012-03-20 Ventana Medical Systems, Inc. Memory management method and apparatus for automated biological reaction system
US6093574A (en) 1997-08-11 2000-07-25 Ventana Medical Systems Method and apparatus for rinsing a microscope slide
AU1574801A (en) * 1999-10-26 2001-05-08 Genometrix Genomics Incorporated Process for requesting biological experiments and for the delivery of experimental information
US20050287925A1 (en) * 2003-02-07 2005-12-29 Nathan Proch Collectible item and code for interactive games
US20060035692A1 (en) * 2002-02-08 2006-02-16 Keith Kirby Collectible item and code for interactive games
WO2003087327A2 (en) 2002-04-11 2003-10-23 Medimmune Vaccines, Inc. Preservation of bioactive materials by freeze dried foam
EP1535232A2 (en) * 2002-06-28 2005-06-01 Applera Corporation A system and method for snp genotype clustering
WO2004055709A2 (en) * 2002-12-13 2004-07-01 Applera Corporation Methods for identifying, viewing, and analyzing syntenic and orthologous genomic regions between two or more species
US20060035252A1 (en) * 2003-04-28 2006-02-16 Applera Corporation Methods and workflows for selecting genetic markers utilizing software tool
US20080235055A1 (en) * 2003-07-17 2008-09-25 Scott Mattingly Laboratory instrumentation information management and control network
US20050038776A1 (en) * 2003-08-15 2005-02-17 Ramin Cyrus Information system for biological and life sciences research
US20050221357A1 (en) * 2003-09-19 2005-10-06 Mark Shannon Normalization of gene expression data
US7570443B2 (en) 2003-09-19 2009-08-04 Applied Biosystems, Llc Optical camera alignment
US7332280B2 (en) * 2003-10-14 2008-02-19 Ronald Levy Classification of patients having diffuse large B-cell lymphoma based upon gene expression
US20050144096A1 (en) * 2003-12-26 2005-06-30 Caramanna George S.Ii Financial visualization and analysis systems
EP1732021A4 (en) * 2004-03-26 2009-07-29 Bio Think Tank Co Ltd Method of searching specific base sequence
EP1612537B1 (en) * 2004-06-30 2012-12-19 Sysmex Corporation Specimen preparation apparatus, specimen preparation/analysis system and specimen plate
JP4757547B2 (en) * 2004-06-30 2011-08-24 シスメックス株式会社 Specimen slide glass
WO2006019892A2 (en) * 2004-07-14 2006-02-23 Invitrogen Corporation Methods and systems for in silico experimental design and for providing a biotechnology product to a customer
JP2006072656A (en) * 2004-09-01 2006-03-16 Hitachi Software Eng Co Ltd Primer design method for real time pcr
US20060111915A1 (en) * 2004-11-23 2006-05-25 Applera Corporation Hypothesis generation
JP2006172313A (en) * 2004-12-17 2006-06-29 Fuji Electric Systems Co Ltd Data check management method and program
US8428882B2 (en) 2005-06-14 2013-04-23 Agency For Science, Technology And Research Method of processing and/or genome mapping of diTag sequences
WO2007021502A1 (en) * 2005-08-10 2007-02-22 Ge Healthcare Bio-Sciences Corp. Quality control methods for arrayed oligonucleotides
US20080215387A1 (en) * 2005-08-22 2008-09-04 Sivakumar Muthusamy Automation of Validation Life Cycle and Providing 100% Paperless Electronic Validation Process
US7853868B2 (en) * 2005-09-02 2010-12-14 Microsoft Corporation Button for adding a new tabbed sheet
US7799530B2 (en) * 2005-09-23 2010-09-21 Celera Corporation Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
US8082516B2 (en) * 2005-11-01 2011-12-20 Lycos, Inc. Preview panel
US20080015947A1 (en) * 2006-07-12 2008-01-17 Swift Lawrence W Online ordering of architectural models
WO2008059314A1 (en) * 2006-11-14 2008-05-22 Centro Internacional De Vacunas Malaria vaccine based on the 200l subunit of the plasmodium vivax msp1 protein
US7962378B2 (en) * 2007-07-05 2011-06-14 International Business Machines Corporation Process and methodology to maintain consistency across disparate interfaced systems
WO2009111475A2 (en) * 2008-03-03 2009-09-11 Heatflow Technologies, Inc. Heat flow polymerase chain reaction systems and methods
US10552710B2 (en) 2009-09-28 2020-02-04 Oracle International Corporation Hierarchical sequential clustering
US10013641B2 (en) * 2009-09-28 2018-07-03 Oracle International Corporation Interactive dendrogram controls
US20120035062A1 (en) 2010-06-11 2012-02-09 Life Technologies Corporation Alternative nucleotide flows in sequencing-by-synthesis methods
EP2633470B1 (en) 2010-10-27 2016-10-26 Life Technologies Corporation Predictive model for use in sequencing-by-synthesis
US10273540B2 (en) 2010-10-27 2019-04-30 Life Technologies Corporation Methods and apparatuses for estimating parameters in a predictive model for use in sequencing-by-synthesis
CN103282873B (en) * 2010-11-12 2016-08-24 生命科技公司 Confirm for experimental determination or the system and method for checking
US9594870B2 (en) 2010-12-29 2017-03-14 Life Technologies Corporation Time-warped background signal for sequencing-by-synthesis operations
WO2012092455A2 (en) 2010-12-30 2012-07-05 Life Technologies Corporation Models for analyzing data from sequencing-by-synthesis operations
WO2012092515A2 (en) 2010-12-30 2012-07-05 Life Technologies Corporation Methods, systems, and computer readable media for nucleic acid sequencing
US20130060482A1 (en) 2010-12-30 2013-03-07 Life Technologies Corporation Methods, systems, and computer readable media for making base calls in nucleic acid sequencing
US9428807B2 (en) 2011-04-08 2016-08-30 Life Technologies Corporation Phase-protecting reagent flow orderings for use in sequencing-by-synthesis
US20130059738A1 (en) 2011-04-28 2013-03-07 Life Technologies Corporation Methods and compositions for multiplex pcr
EP3072977B1 (en) 2011-04-28 2018-09-19 Life Technologies Corporation Methods and compositions for multiplex pcr
US20130059762A1 (en) 2011-04-28 2013-03-07 Life Technologies Corporation Methods and compositions for multiplex pcr
US9123002B2 (en) * 2011-05-27 2015-09-01 Abbott Informatics Corporation Graphically based method for developing rules for managing a laboratory workflow
US8751488B2 (en) 2011-08-24 2014-06-10 Waypart, Inc. Part number search method and system
US10704164B2 (en) 2011-08-31 2020-07-07 Life Technologies Corporation Methods, systems, computer readable media, and kits for sample identification
WO2013081864A1 (en) 2011-11-29 2013-06-06 Life Technologies Corporation Methods and compositions for multiplex pcr
EP2966180B1 (en) 2011-11-29 2017-08-16 Life Technologies Corporation Methods and compositions for multiplex pcr
US9646132B2 (en) 2012-05-11 2017-05-09 Life Technologies Corporation Models for analyzing data from sequencing-by-synthesis operations
US9201916B2 (en) * 2012-06-13 2015-12-01 Infosys Limited Method, system, and computer-readable medium for providing a scalable bio-informatics sequence search on cloud
US20150167068A1 (en) 2012-07-13 2015-06-18 Life Technologies Corporation HUMAN IDENTIFICATION USING A PANEL OF SNPs
US10329608B2 (en) 2012-10-10 2019-06-25 Life Technologies Corporation Methods, systems, and computer readable media for repeat sequencing
WO2014071404A2 (en) * 2012-11-05 2014-05-08 Firefly Bioworks, Inc. Automated product customization based upon literature search results
US20140296080A1 (en) 2013-03-14 2014-10-02 Life Technologies Corporation Methods, Systems, and Computer Readable Media for Evaluating Variant Likelihood
EP3570040B1 (en) 2013-04-05 2024-02-14 F. Hoffmann-La Roche AG Analysis method for a biological sample
US9926597B2 (en) 2013-07-26 2018-03-27 Life Technologies Corporation Control nucleic acid sequences for use in sequencing-by-synthesis and methods for designing the same
CN106029899B (en) * 2013-09-30 2021-08-03 深圳华大基因股份有限公司 Method, system and computer readable medium for determining SNP information in predetermined region of chromosome
US10410739B2 (en) 2013-10-04 2019-09-10 Life Technologies Corporation Methods and systems for modeling phasing effects in sequencing using termination chemistry
WO2015069713A2 (en) * 2013-11-05 2015-05-14 Firefly Bioworks, Inc. Systems and methods for automated multiplex assay design
US10676787B2 (en) 2014-10-13 2020-06-09 Life Technologies Corporation Methods, systems, and computer-readable media for accelerated base calling
US10317420B2 (en) 2014-12-15 2019-06-11 Luminex Corporation Detailed assay protocol specification
EP3295345B1 (en) 2015-05-14 2023-01-25 Life Technologies Corporation Barcode sequences, and related systems and methods
US9766969B2 (en) * 2015-06-18 2017-09-19 Xerox Corporation Assessing and improving quality of event logs including prioritizing and classifying errors into error-perspective and error-type classifications
CN113358860A (en) * 2015-07-23 2021-09-07 中尺度技术有限责任公司 Automated analysis system and method for performing analysis in such a system
JP6220464B1 (en) * 2016-03-14 2017-10-25 神戸バイオロボティクス株式会社 Sample storage body and sample storage body automatic processing system
US10619205B2 (en) 2016-05-06 2020-04-14 Life Technologies Corporation Combinatorial barcode sequences, and related systems and methods
US20180057866A1 (en) * 2016-08-08 2018-03-01 Exploragen, Inc. Genetic profiling methods for prediction of taste and scent preferences and gustative and olfactive product selection
US10622095B2 (en) * 2017-07-21 2020-04-14 Helix OpCo, LLC Genomic services platform supporting multiple application providers
US10296842B2 (en) 2017-07-21 2019-05-21 Helix OpCo, LLC Genomic services system with dual-phase genotype imputation
EP3467690A1 (en) * 2017-10-06 2019-04-10 Emweb bvba Improved alignment method for nucleic acid sequences
CN109871941B (en) * 2019-02-18 2020-02-21 中科寒武纪科技股份有限公司 Data processing method and device and related products
AU2020291343A1 (en) * 2019-06-14 2021-12-02 Seegene, Inc. Computer-implemented method for collaborative development of reagents for detection of target nucleic acids
US11361847B1 (en) 2021-02-06 2022-06-14 Timothy A. Hodge System and method for rapidly reporting testing results
US11864010B2 (en) * 2021-07-02 2024-01-02 Cisco Technology, Inc. Automated activation of unsolicited probe responses
WO2023081627A1 (en) * 2021-11-02 2023-05-11 Koireader Technologies, Inc. System for transportation and shipping related data extraction

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5374395A (en) * 1993-10-14 1994-12-20 Amoco Corporation Diagnostics instrument
US5948360A (en) * 1994-07-11 1999-09-07 Tekmar Company Autosampler with robot arm
US6271002B1 (en) * 1999-10-04 2001-08-07 Rosetta Inpharmatics, Inc. RNA amplification method
US20010039014A1 (en) * 2000-01-11 2001-11-08 Maxygen, Inc. Integrated systems and methods for diversity generation and screening
US6316230B1 (en) * 1999-08-13 2001-11-13 Applera Corporation Polymerase extension at 3′ terminus of PNA-DNA chimera
US6329139B1 (en) * 1995-04-25 2001-12-11 Discovery Partners International Automated sorting system for matrices with memory
US20020034754A1 (en) * 1999-12-08 2002-03-21 Reed Michael W. Fluorescent quenching detection reagents and methods
US6456942B1 (en) * 1998-01-25 2002-09-24 Combimatrix Corporation Network infrastructure for custom microarray synthesis and analysis
US6480791B1 (en) * 1998-10-28 2002-11-12 Michael P. Strathmann Parallel methods for genomic analysis
US6511277B1 (en) * 2000-07-10 2003-01-28 Affymetrix, Inc. Cartridge loader and methods
US20030082544A1 (en) * 2001-07-11 2003-05-01 Third Wave Technologies, Inc. Methods and systems for validating detection assays, developing in-vitro diagnostic DNA or RNA analysis products, and increasing revenue and/or profit margins from in-vitro diagnostic DNA or RNA analysis assays

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US39014A (en) * 1863-06-23 Improvement in harvesters
DE3529478A1 (en) 1985-08-16 1987-02-19 Boehringer Mannheim Gmbh 7-DESAZA-2'DESOXYGUANOSINE NUCLEOTIDES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE FOR NUCLEIC ACID SEQUENCING
US5081584A (en) 1989-03-13 1992-01-14 United States Of America Computer-assisted design of anti-peptides based on the amino acid sequence of a target peptide
DE3924424A1 (en) 1989-07-24 1991-01-31 Boehringer Mannheim Gmbh NUCLEOSIDE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS A MEDICINAL PRODUCT AND THEIR USE IN THE SEQUENCING OF NUCLEIC ACID
US5670633A (en) 1990-01-11 1997-09-23 Isis Pharmaceuticals, Inc. Sugar modified oligonucleotides that detect and modulate gene expression
DK51092D0 (en) 1991-05-24 1992-04-15 Ole Buchardt OLIGONUCLEOTIDE ANALOGUE DESCRIBED BY PEN, MONOMERIC SYNTHONES AND PROCEDURES FOR PREPARING THEREOF, AND APPLICATIONS THEREOF
US5582986A (en) 1991-06-14 1996-12-10 Isis Pharmaceuticals, Inc. Antisense oligonucleotide inhibition of the ras gene
DE4140463A1 (en) 1991-12-09 1993-06-17 Boehringer Mannheim Gmbh 2'-DESOXY-ISOGUANOSINE, THE ISOSTERAL ANALOGS AND THE APPLICATION THEREOF
US6300058B1 (en) 1992-01-29 2001-10-09 Hitachi Chemical Research Center, Inc. Method for measuring messenger RNA
JPH0778804B2 (en) * 1992-05-28 1995-08-23 日本アイ・ビー・エム株式会社 Scene information input system and method
ATE282695T1 (en) 1992-07-20 2004-12-15 Isis Pharmaceuticals Inc PSEUDO HALF-KNOT FORMING RNA THROUGH HYBRIDIZATION OF ANTISESEOLIGON NUCLEOTIDES TO TARGETED RNA SECONDARY STRUCTURES
US5556749A (en) 1992-11-12 1996-09-17 Hitachi Chemical Research Center, Inc. Oligoprobe designstation: a computerized method for designing optimal DNA probes
US5593834A (en) 1993-06-17 1997-01-14 The Research Foundation Of State University Of New York Method of preparing DNA sequences with known ligand binding characteristics
EP1245286B1 (en) * 1993-10-22 2009-11-25 Abbott Laboratories Reaction tube and method of use to minimize contamination
WO1996001693A1 (en) * 1994-07-11 1996-01-25 Akzo Nobel N.V. Micro sample tube with reduced dead volume and bar code capability
US5846719A (en) 1994-10-13 1998-12-08 Lynx Therapeutics, Inc. Oligonucleotide tags for sorting and identification
US5727163A (en) * 1995-03-30 1998-03-10 Amazon.Com, Inc. Secure method for communicating credit card data when placing an order on a non-secure network
GB9524381D0 (en) * 1995-11-29 1996-01-31 Anthony Nolan Bone Marrow Trus Method for identifying an unknown allele
EP1179600B1 (en) 1996-06-04 2005-05-11 University Of Utah Research Foundation Monitoring hybridization during PCR
US5825881A (en) * 1996-06-28 1998-10-20 Allsoft Distributing Inc. Public network merchandising system
US6189013B1 (en) * 1996-12-12 2001-02-13 Incyte Genomics, Inc. Project-based full length biomolecular sequence database
US6058373A (en) * 1996-10-16 2000-05-02 Microsoft Corporation System and method for processing electronic order forms
US6100030A (en) * 1997-01-10 2000-08-08 Pioneer Hi-Bred International, Inc. Use of selective DNA fragment amplification products for hybridization-based genetic fingerprinting, marker assisted selection, and high-throughput screening
JP3485435B2 (en) * 1997-04-04 2004-01-13 三菱電機株式会社 Method for manufacturing semiconductor device
US6143877A (en) 1997-04-30 2000-11-07 Epoch Pharmaceuticals, Inc. Oligonucleotides including pyrazolo[3,4-D]pyrimidine bases, bound in double stranded nucleic acids
US5960411A (en) * 1997-09-12 1999-09-28 Amazon.Com, Inc. Method and system for placing a purchase order via a communications network
US6251588B1 (en) 1998-02-10 2001-06-26 Agilent Technologies, Inc. Method for evaluating oligonucleotide probe sequences
US6127121A (en) 1998-04-03 2000-10-03 Epoch Pharmaceuticals, Inc. Oligonucleotides containing pyrazolo[3,4-D]pyrimidines for hybridization and mismatch discrimination
JPH11354541A (en) * 1998-06-11 1999-12-24 Fujitsu Quantum Devices Kk Semiconductor device and its manufacture
KR20000021073A (en) * 1998-09-25 2000-04-15 박원배 Inhibitors for biosynthesis of cholesterol
US7013221B1 (en) * 1999-07-16 2006-03-14 Rosetta Inpharmatics Llc Iterative probe design and detailed expression profiling with flexible in-situ synthesis arrays
EP1214331B1 (en) 1999-08-30 2006-10-11 Roche Diagnostics GmbH 2-azapurine compounds and their use
WO2001037167A1 (en) 1999-11-16 2001-05-25 Regency Ventures Ltd, Charted Corporation Services A method and system for configurating products
US6660845B1 (en) 1999-11-23 2003-12-09 Epoch Biosciences, Inc. Non-aggregating, non-quenching oligomers comprising nucleotide analogues; methods of synthesis and use thereof
US6282550B1 (en) * 2000-01-10 2001-08-28 Tangerine Technologies, Inc. Apparatus and method of utilizing a database to correlate customer requests and suppliers capabilities for custom synthesis of polymers
EP1252513A4 (en) 2000-01-25 2007-07-18 Affymetrix Inc Method, system and computer software for providing a genomic web portal
AU2001240991A1 (en) * 2000-03-15 2001-09-24 Genset Methods, software, and apparati for designing, ordering, pricing, tracking and directing production of custom biologicals
JP2001258568A (en) 2000-03-22 2001-09-25 Hitachi Ltd Primer design system
WO2002037391A2 (en) * 2000-11-03 2002-05-10 Myetribute, Inc. System and method for conducting pet, death, dna and other related transactions over a computer network
US7117095B2 (en) 2000-11-21 2006-10-03 Affymetrix, Inc. Methods for selecting nucleic acid probes
WO2002044994A2 (en) * 2000-11-30 2002-06-06 Third Wave Technologies, Inc. Systems and methods for detection assay ordering, design, production, inventory, sales and analysis for use with or in a production facility
US20040014067A1 (en) 2001-10-12 2004-01-22 Third Wave Technologies, Inc. Amplification methods and compositions
JP2005516296A (en) 2002-01-25 2005-06-02 アプレラ コーポレイション Computer operating method and / or computer network for arranging biotechnology products
US20030190652A1 (en) 2002-01-25 2003-10-09 De La Vega Francisco M. Methods of validating SNPs and compiling libraries of assays
US20040018506A1 (en) 2002-01-25 2004-01-29 Koehler Ryan T. Methods for placing, accepting, and filling orders for products and services
AU2003298706A1 (en) 2002-12-04 2004-06-23 Applera Corporation Multiplex amplification of polynucleotides
WO2004055709A2 (en) 2002-12-13 2004-07-01 Applera Corporation Methods for identifying, viewing, and analyzing syntenic and orthologous genomic regions between two or more species
US7430496B2 (en) 2004-06-16 2008-09-30 Tokyo Electron Limited Method and apparatus for using a pressure control system to monitor a plasma processing system

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5374395A (en) * 1993-10-14 1994-12-20 Amoco Corporation Diagnostics instrument
US5948360A (en) * 1994-07-11 1999-09-07 Tekmar Company Autosampler with robot arm
US6329139B1 (en) * 1995-04-25 2001-12-11 Discovery Partners International Automated sorting system for matrices with memory
US6456942B1 (en) * 1998-01-25 2002-09-24 Combimatrix Corporation Network infrastructure for custom microarray synthesis and analysis
US6480791B1 (en) * 1998-10-28 2002-11-12 Michael P. Strathmann Parallel methods for genomic analysis
US6316230B1 (en) * 1999-08-13 2001-11-13 Applera Corporation Polymerase extension at 3′ terminus of PNA-DNA chimera
US6271002B1 (en) * 1999-10-04 2001-08-07 Rosetta Inpharmatics, Inc. RNA amplification method
US20020034754A1 (en) * 1999-12-08 2002-03-21 Reed Michael W. Fluorescent quenching detection reagents and methods
US20010039014A1 (en) * 2000-01-11 2001-11-08 Maxygen, Inc. Integrated systems and methods for diversity generation and screening
US6511277B1 (en) * 2000-07-10 2003-01-28 Affymetrix, Inc. Cartridge loader and methods
US20030082544A1 (en) * 2001-07-11 2003-05-01 Third Wave Technologies, Inc. Methods and systems for validating detection assays, developing in-vitro diagnostic DNA or RNA analysis products, and increasing revenue and/or profit margins from in-vitro diagnostic DNA or RNA analysis assays

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9464320B2 (en) 2002-01-25 2016-10-11 Applied Biosystems, Llc Methods for placing, accepting, and filling orders for products and services
US10689692B2 (en) 2002-01-25 2020-06-23 Applied Biosystems, Llc Methods for placing, accepting, and filling orders for products and services
US20110175343A1 (en) * 2005-01-31 2011-07-21 Pipe Maintenance, Inc. Identification system for drill pipes and the like
US20100285986A1 (en) * 2007-11-02 2010-11-11 Friedrich Menges Single-step multiplex immunoassay
US9229000B2 (en) * 2007-11-02 2016-01-05 Zenteris Gmbh Single-step multiplex immunoassay
US10677810B2 (en) 2016-10-07 2020-06-09 Brooks Automation, Inc. Sample tube and method

Also Published As

Publication number Publication date
JP2005516300A (en) 2005-06-02
WO2003065146A3 (en) 2004-09-10
AU2003209375A1 (en) 2003-09-02
US20050282162A1 (en) 2005-12-22
CA2474482A1 (en) 2003-08-07
WO2003065000A2 (en) 2003-08-07
US10689692B2 (en) 2020-06-23
EP1468103A1 (en) 2004-10-20
US20120303472A1 (en) 2012-11-29
JP2006294059A (en) 2006-10-26
EP1468103A4 (en) 2008-12-31
US20170268051A1 (en) 2017-09-21
US20200392571A1 (en) 2020-12-17
EP1706826A2 (en) 2006-10-04
EP1706826A4 (en) 2008-01-30
US20080228589A1 (en) 2008-09-18
US20040063109A2 (en) 2004-04-01
US20040018506A1 (en) 2004-01-29
US9464320B2 (en) 2016-10-11
JP2005515785A (en) 2005-06-02
WO2003064670A1 (en) 2003-08-07
WO2003065000A3 (en) 2004-10-07
WO2003065146A2 (en) 2003-08-07

Similar Documents

Publication Publication Date Title
US20030175774A1 (en) Single-tube, ready-to-use assay kits and methods using same
US20090239290A1 (en) Single-tube, ready-to-use assay kits, and methods using same
He et al. SNP genotyping: the KASP assay
US20060147955A1 (en) Single step detection assay
EP0567635B1 (en) Rapid assays for amplification products
AU2004282593B8 (en) Direct nucleic acid detection in bodily fluids
US7344831B2 (en) Methods for controlling cross-hybridization in analysis of nucleic acid sequences
US20090068664A1 (en) Amplification methods and compositions
O'Flaherty et al. Steady‐State Kinetic Analysis of DNA Polymerase Single‐Nucleotide Incorporation Products
US20040072195A1 (en) Single-tube, ready-to-use assay kits, and methods using same
US20090239233A1 (en) Single-tube, ready-to-use assay kits, and methods using same
US20030219784A1 (en) Systems and methods for analysis of agricultural products
Cahill et al. Exo-proofreading, a versatile SNP scoring technology
JP4219389B2 (en) Detection of mutations in amplification primers and pooled samples
Regan et al. Phasing DNA markers using digital PCR
Neri et al. Transferring automation for large-scale development and production of invader SNP assays
CN101341258A (en) Single step detection assay
Laveroni et al. Quantitative PCR of Alu Repeats Using PowerUp™ SYBR® Green Master Mix
WO2024081873A1 (en) Methods for evaluating health and stability of cultured cells
Zhou et al. Single nucleotide polymorphism mapping array assay
JP2007521016A (en) Direct nucleic acid detection in body fluids
MXPA06004311A (en) Direct nucleic acid detection in bodily fluids

Legal Events

Date Code Title Description
AS Assignment

Owner name: APPLERA CORPORATION, CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HUNKAPILLER, MICHAEL W.;GILBERT, DENNIS A.;LIVAK, KENNETH J.;AND OTHERS;REEL/FRAME:014105/0954;SIGNING DATES FROM 20030422 TO 20030506

Owner name: APPLERA CORPORATION, CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HUNKAPILLER, MICHAEL W.;GILBERT, DENNIS A.;LIVAK, KENNETH J.;AND OTHERS;SIGNING DATES FROM 20030422 TO 20030506;REEL/FRAME:014105/0954

AS Assignment

Owner name: APPLERA CORPORATION, CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HUNKAPILLER, MICHAEL W.;GILBERT, DENNIS A.;LIVAK, KENNETH J.;AND OTHERS;SIGNING DATES FROM 20030422 TO 20030506;REEL/FRAME:018551/0927

Owner name: APPLERA CORPORATION, CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HUNKAPILLER, MICHAEL W.;GILBERT, DENNIS A.;LIVAK, KENNETH J.;AND OTHERS;REEL/FRAME:018551/0927;SIGNING DATES FROM 20030422 TO 20030506

AS Assignment

Owner name: BANK OF AMERICA, N.A, AS COLLATERAL AGENT, WASHING

Free format text: SECURITY AGREEMENT;ASSIGNOR:APPLIED BIOSYSTEMS, LLC;REEL/FRAME:021976/0001

Effective date: 20081121

Owner name: BANK OF AMERICA, N.A, AS COLLATERAL AGENT,WASHINGT

Free format text: SECURITY AGREEMENT;ASSIGNOR:APPLIED BIOSYSTEMS, LLC;REEL/FRAME:021976/0001

Effective date: 20081121

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

AS Assignment

Owner name: APPLIED BIOSYSTEMS, LLC, CALIFORNIA

Free format text: MERGER;ASSIGNOR:ATOM ACQUISITION, LLC & APPLIED BIOSYSTEMS INC.;REEL/FRAME:022852/0370

Effective date: 20081121

Owner name: APPLIED BIOSYSTEMS INC., CALIFORNIA

Free format text: CHANGE OF NAME;ASSIGNOR:APPLERA CORPORATION;REEL/FRAME:022852/0343

Effective date: 20080630

Owner name: APPLIED BIOSYSTEMS, INC., CALIFORNIA

Free format text: MERGER;ASSIGNOR:ATOM ACQUISITION CORPORATION;REEL/FRAME:022852/0358

Effective date: 20081121

AS Assignment

Owner name: APPLIED BIOSYSTEMS INC.,CALIFORNIA

Free format text: CHANGE OF NAME;ASSIGNOR:APPLERA CORPORATION;REEL/FRAME:023994/0538

Effective date: 20080701

Owner name: APPLIED BIOSYSTEMS, LLC,CALIFORNIA

Free format text: MERGER;ASSIGNOR:APPLIED BIOSYSTEMS INC.;REEL/FRAME:023994/0587

Effective date: 20081121

Owner name: APPLIED BIOSYSTEMS, LLC,CALIFORNIA

Free format text: MERGER;ASSIGNOR:APPLIED BIOSYSTEMS INC.;REEL/FRAME:023985/0801

Effective date: 20081121

Owner name: APPLIED BIOSYSTEMS, LLC, CALIFORNIA

Free format text: MERGER;ASSIGNOR:APPLIED BIOSYSTEMS INC.;REEL/FRAME:023985/0801

Effective date: 20081121

Owner name: APPLIED BIOSYSTEMS INC., CALIFORNIA

Free format text: CHANGE OF NAME;ASSIGNOR:APPLERA CORPORATION;REEL/FRAME:023994/0538

Effective date: 20080701

Owner name: APPLIED BIOSYSTEMS, LLC, CALIFORNIA

Free format text: MERGER;ASSIGNOR:APPLIED BIOSYSTEMS INC.;REEL/FRAME:023994/0587

Effective date: 20081121

AS Assignment

Owner name: APPLIED BIOSYSTEMS, INC., CALIFORNIA

Free format text: LIEN RELEASE;ASSIGNOR:BANK OF AMERICA, N.A.;REEL/FRAME:030182/0677

Effective date: 20100528

AS Assignment

Owner name: APPLIED BIOSYSTEMS, LLC, CALIFORNIA

Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY NAME PREVIOUSLY RECORDED AT REEL: 030182 FRAME: 0697. ASSIGNOR(S) HEREBY CONFIRMS THE RELEASE OF SECURITY INTEREST;ASSIGNOR:BANK OF AMERICA, N.A.;REEL/FRAME:038002/0697

Effective date: 20100528

Owner name: APPLIED BIOSYSTEMS, LLC, CALIFORNIA

Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY NAME PREVIOUSLY RECORDED AT REEL: 030182 FRAME: 0677. ASSIGNOR(S) HEREBY CONFIRMS THE RELEASE OF SECURITY INTEREST;ASSIGNOR:BANK OF AMERICA, N.A.;REEL/FRAME:038002/0697

Effective date: 20100528